<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC3915084/results/search/disease/results.xml">
   <result pre="which could be used as very effective natural remedies against" exact="candidiasis" post="caused by C. albicans. Introduction The interest in natural"/>
   <result pre="The use of lemon essential oils in all kinds of" exact="candidiasis" post="seems to be an interesting solution because of their"/>
   <result pre="use of lemon essential oil-based products as natural remedies against" exact="candidiasis" post="caused by C. albicans. Conclusions Lemon essential oils with"/>
   <result pre="content of monoterpenoids may be an ingredient of products against" exact="candidiasis" post="caused by Candida. Avicenna-Oil and ETJA contain citral and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC3953398/results/search/disease/results.xml">
   <result pre="receptor agonist and has been shown to improve Alzheimer presenile" exact="dementia" post="in certain patients after parenteral administration [ 1 –"/>
   <result pre="areca nut, causes neurotoxicity through enhancement of oxidative stress and" exact="suppression" post="of the antioxidant protective system Free Radical Biology and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC3954529/results/search/disease/results.xml">
   <result pre="Members of this family of alkaloids exhibit cytotoxicity against murine" exact="leukemia" post="(L1210, P-388, and A-549 cell lines), demonstrate antioxidant activity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC3961117/results/search/disease/results.xml">
   <result pre="Wardenburg J Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus" exact="pneumonia" post="Infect Immun 77 2712 2718 2009 [19380475] 10 Gurieva"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC3977348/results/search/disease/results.xml">
   <result pre="2008). Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human" exact="ovarian cancer" post="cells. Gene 414 95– 105 [10.1016/j.gene.2008.02.015] [18372118] Shinohara R."/>
   <result pre="Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian" exact="cancer" post="cells. Gene 414 95– 105 [10.1016/j.gene.2008.02.015] [18372118] Shinohara R."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4005389/results/search/disease/results.xml">
   <result pre="downstream of PLC-coupled bradykinin (BK 2) receptors [59] to establish" exact="hypersensitivity" post="to heat [56] . It has finally to be"/>
   <result pre="2009) A cross-sectional cohort survey in 2100 patients with painful" exact="diabetic neuropathy" post="and postherpetic neuralgia: Differences in demographic data and sensory"/>
   <result pre="A cross-sectional cohort survey in 2100 patients with painful diabetic" exact="neuropathy" post="and postherpetic neuralgia: Differences in demographic data and sensory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4007251/results/search/disease/results.xml">
   <result pre="gastrointestinal complaints, flatulence, irritable stomach, indigestion, lack of appetite and" exact="dyspepsia" post="in adults[ 2 3 ]. Cinnamon oil is used"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4079982/results/search/disease/results.xml">
   <result pre="contribute to the biomedical knowledge required to solve today's rising" exact="obesity" post="and diabetes rates. Conflict of interest statement The authors"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4115348/results/search/disease/results.xml">
   <result pre="Moreover, in some conditions such as gastrointestinal ulcers and bronchial" exact="hypersensitivity" post="to aspirin, taking them is contraindicated.[ 10 ] On"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4161876/results/search/disease/results.xml">
   <result pre="mediate sperm chemotaxis [ 25 ]. Selected ORs accumulate in" exact="prostate cancer" post="to inhibit proliferation [ 26 ]. Olfr16, a well-characterized"/>
   <result pre="sperm chemotaxis [ 25 ]. Selected ORs accumulate in prostate" exact="cancer" post="to inhibit proliferation [ 26 ]. Olfr16, a well-characterized"/>
   <result pre="ORs is also detected in human SN, the site of" exact="neurodegeneration" post="in PD, and is found regulated in PD post"/>
   <result pre="KF Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in" exact="schizophrenia" post="Nat Neurosci 2002 5 3 267 271 [10.1038/nn804] [11865311]"/>
   <result pre="Hatt H Activation of an olfactory receptor inhibits proliferation of" exact="prostate cancer" post="cells J Biol Chem 2009 284 24 16218 16225"/>
   <result pre="H Activation of an olfactory receptor inhibits proliferation of prostate" exact="cancer" post="cells J Biol Chem 2009 284 24 16218 16225"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4202545/results/search/disease/results.xml">
   <result pre="properly.] [] [] [] Abstract Introduction Regarding chronic nature of" exact="epilepsy" post="and its side effects and to access the effective"/>
   <result pre="other traditional antiepileptic medications. 1. Introduction Epilepsy is a chronic" exact="neurological disorder" post="of the brain that affects about 70 million people"/>
   <result pre="patients, millions (500,000 people in the USA alone) have uncontrolled" exact="epilepsy" post="(Roger, Porter, Brian, &amp;amp; Meldrum, 2009 ). Regarding chronic"/>
   <result pre="is due to the presence of AGS components which induce" exact="suppression" post="of nuclear transcriptional factor, but other plausible mechanisms can"/>
   <result pre="weeks Anethum graveolens (dill) on metabolic markers in patients with" exact="metabolic syndrome;" post="a randomized double blind controlled trial . Daru, 20,"/>
   <result pre="O. ( 2009). Maternal epileptic seizure induced by pentylenetetrazol: apoptotic" exact="neurodegeneration" post="and decreased GABAB1 receptor expression in prenatal rat brain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4220615/results/search/disease/results.xml">
   <result pre="to the World Health Organization (WHO), the overall impact of" exact="cancer" post="has increased by more than the double in the"/>
   <result pre="estimated that in 2008 there were roughly 12 million new" exact="cancer" post="cases and seven million deaths worldwide. Future projections indicate"/>
   <result pre="cases and seven million deaths worldwide. Future projections indicate that" exact="cancer" post="mortality will continue to rise, reaching 11.4 million in"/>
   <result pre="and more than two thirds of the drugs used in" exact="cancer" post="treatment come directly from natural products or are developed"/>
   <result pre="of new bioactive natural products [ 5 ], including against" exact="cancer" post="[ 6 , 7 ]. For example, Piaru and"/>
   <result pre="is a major cause of death worldwide, ranked behind only" exact="cardiovascular disease." post="Considering that monoterpenes are common in many plant species"/>
   <result pre="and camphor caused inhibition of the growth of the human" exact="colon cancer" post="cell lines (HCT-116 p53+/+ and p53−/−) and were inactive"/>
   <result pre="camphor caused inhibition of the growth of the human colon" exact="cancer" post="cell lines (HCT-116 p53+/+ and p53−/−) and were inactive"/>
   <result pre="line; HeLa, an epithelioid carcinomic cell line; MOLT-4, a human" exact="lymphoblastic leukemia" post="T cell line; K-562, a human chronic myelogenous leukemia"/>
   <result pre="HeLa, an epithelioid carcinomic cell line; MOLT-4, a human lymphoblastic" exact="leukemia" post="T cell line; K-562, a human chronic myelogenous leukemia"/>
   <result pre="lymphoblastic leukemia T cell line; K-562, a human chronic myelogenous" exact="leukemia" post="cell line; and CTVR-1, an early B cell line"/>
   <result pre="line from the bone marrow cells of a patient with" exact="acute myeloid leukemia" post="[ 14 ]. Different officinal plants of Lebanon, among"/>
   <result pre="from the bone marrow cells of a patient with acute" exact="myeloid leukemia" post="[ 14 ]. Different officinal plants of Lebanon, among"/>
   <result pre="the bone marrow cells of a patient with acute myeloid" exact="leukemia" post="[ 14 ]. Different officinal plants of Lebanon, among"/>
   <result pre="(IC 50) was the highest of 12, for mouse P388" exact="leukemia" post="cell among others. 1.3. Menthol Menthol was cytotoxic for"/>
   <result pre="cell among others. 1.3. Menthol Menthol was cytotoxic for murine" exact="leukemia" post="WEHI-3 cells in a concentration-dependent manner. The in vivo"/>
   <result pre="] showed that menthol inhibited the proliferation and motility of" exact="prostate cancer" post="DU145 cells. Li and collaborators [ 22 ] demonstrated"/>
   <result pre="showed that menthol inhibited the proliferation and motility of prostate" exact="cancer" post="DU145 cells. Li and collaborators [ 22 ] demonstrated"/>
   <result pre="induced cell death via the TRPM8 channel in a human" exact="bladder cancer" post="cell line. Okamoto and collaborators [ 23 ] also"/>
   <result pre="cell death via the TRPM8 channel in a human bladder" exact="cancer" post="cell line. Okamoto and collaborators [ 23 ] also"/>
   <result pre="vitro cytotoxic effects against Ehrlich's ascites carcinoma and KATO-III human" exact="stomach cancer" post="cell line [ 24 ]. 1.5. Alpha- and Gamma-Thujaplicin"/>
   <result pre="cytotoxic effects against Ehrlich's ascites carcinoma and KATO-III human stomach" exact="cancer" post="cell line [ 24 ]. 1.5. Alpha- and Gamma-Thujaplicin"/>
   <result pre="inhibited cell growth of Ehrlich's ascites carcinoma and KATO-III human" exact="stomach cancer" post="[ 25 ]. Gama-thujaplicin also showed strong cytotoxic effects"/>
   <result pre="cell growth of Ehrlich's ascites carcinoma and KATO-III human stomach" exact="cancer" post="[ 25 ]. Gama-thujaplicin also showed strong cytotoxic effects"/>
   <result pre="27 ] demonstrated that borneol potentiates selenocystine-induced apoptosis in human" exact="hepatocellular carcinoma" post="cells by enhancement of cellular uptake and activation of"/>
   <result pre="and 18.4  μg/mL, respectively. Results from in vivo studies using" exact="sarcoma" post="180 as a tumor model demonstrated inhibition rates of"/>
   <result pre="20 mg/kg. 1.8. Carvacrol Carvacrol produced significant cytotoxic activity against mouse" exact="leukemia" post="P388 [ 30 ] and Hep-2 [ 31 ]."/>
   <result pre="addition of vitamin C and vitamin E. In the P815" exact="mastocytoma" post="cell line, carvacrol showed a dose-dependent cytotoxic effect, but"/>
   <result pre="mechanism of carvacrol-induced cell death in MDA-MB 231 human metastatic" exact="breast cancer" post="cells and demonstrated that this compound induced apoptosis in"/>
   <result pre="of carvacrol-induced cell death in MDA-MB 231 human metastatic breast" exact="cancer" post="cells and demonstrated that this compound induced apoptosis in"/>
   <result pre="oil and carvacrol have pharmacological importance for the prevention of" exact="cancer" post="because of its significant antimutagenicity effect [ 41 ]."/>
   <result pre="significant evidence for antioxidant activity and cytotoxic activity against mouse" exact="leukemia" post="P388 cells [ 31 ]. Ferraz and collaborators ["/>
   <result pre="presented cytotoxic effect against Hep-2 cells [ 35 ], P815" exact="mastocytoma" post="cells [ 31 ], HepG2 human hepatoma cells, Caco-2"/>
   <result pre="Thymol showed antioxidant activity and cytotoxic activity against the mouse" exact="leukemia" post="P388 cell line [ 30 , 44 ]. Jayakumar"/>
   <result pre="activity for thymohydroquinone in squamous cell carcinoma (SCC VII) and" exact="fibrosarcoma" post="(FsaR) cell lines. This activity was dose dependent and"/>
   <result pre="mechanism could be implicated in the induction of apoptosis in" exact="cancer" post="cells. The activity of thymoquinone against nonsmall cell lung"/>
   <result pre="in cancer cells. The activity of thymoquinone against nonsmall cell" exact="lung cancer" post="(NSCLC) and small cell lung cancer (SCLC) cell lines,"/>
   <result pre="cancer cells. The activity of thymoquinone against nonsmall cell lung" exact="cancer" post="(NSCLC) and small cell lung cancer (SCLC) cell lines,"/>
   <result pre="thymoquinone against nonsmall cell lung cancer (NSCLC) and small cell" exact="lung cancer" post="(SCLC) cell lines, alone and in combination with cisplatin"/>
   <result pre="against nonsmall cell lung cancer (NSCLC) and small cell lung" exact="cancer" post="(SCLC) cell lines, alone and in combination with cisplatin"/>
   <result pre="Sethi and collaborators [ 56 ] evaluated the involvement of" exact="suppression" post="of the NF- κB activation pathway in apoptosis induced"/>
   <result pre="stress response pathway sensor CHEK1 and contributed to apoptosis in" exact="colorectal cancer" post="cells. In human, multiple myeloma cells thymoquinone inhibited proliferation,"/>
   <result pre="response pathway sensor CHEK1 and contributed to apoptosis in colorectal" exact="cancer" post="cells. In human, multiple myeloma cells thymoquinone inhibited proliferation,"/>
   <result pre="and contributed to apoptosis in colorectal cancer cells. In human," exact="multiple myeloma" post="cells thymoquinone inhibited proliferation, induced apoptosis, and induced chemosensitization,"/>
   <result pre="cells thymoquinone inhibited proliferation, induced apoptosis, and induced chemosensitization, through" exact="suppression" post="of the signal transducer and activator of transcription 3"/>
   <result pre="] demonstrated a powerful chemopreventive activity for thymoquinone against MC-induced" exact="fibrosarcoma" post="tumors, suggesting that its mechanisms of action include antioxidant"/>
   <result pre="these substances may be an effective treatment option against human" exact="osteosarcoma" post="cells. The utilization of thymoquinone in the treatment of"/>
   <result pre="cells. The utilization of thymoquinone in the treatment of human" exact="osteosarcoma" post="is also suggested by Roepke and collaborators [ 62"/>
   <result pre="important because loss of p53 function is frequently observed in" exact="osteosarcoma" post="patients. In contrast, Peng and collaborators [ 63 ]"/>
   <result pre="63 ] demonstrated antitumor and antiangiogenesis effects of thymoquinone on" exact="osteosarcoma" post="through the NF- κB pathway. Yazan and collaborators ["/>
   <result pre="involved in mediating thymoquinone-induced apoptosis in a panel of human" exact="colon cancer" post="cells (Caco-2, HCT-116, LoVo, DLD-1, and HT-29) through activation"/>
   <result pre="in mediating thymoquinone-induced apoptosis in a panel of human colon" exact="cancer" post="cells (Caco-2, HCT-116, LoVo, DLD-1, and HT-29) through activation"/>
   <result pre="of antioxidants with thymoquinone may be a means of treating" exact="prostate cancer" post="safely and effectively. In HEp-2 human laryngeal carcinoma cells,"/>
   <result pre="antioxidants with thymoquinone may be a means of treating prostate" exact="cancer" post="safely and effectively. In HEp-2 human laryngeal carcinoma cells,"/>
   <result pre="caspase 9) is related to thymoquinone-induced apoptosis in p53-null HL-60" exact="cancer" post="cells [ 72 ]. In prostate cancer cells, thymoquinone"/>
   <result pre="apoptosis in p53-null HL-60 cancer cells [ 72 ]. In" exact="prostate cancer" post="cells, thymoquinone induced GSH depletion and increased ROS generation"/>
   <result pre="in p53-null HL-60 cancer cells [ 72 ]. In prostate" exact="cancer" post="cells, thymoquinone induced GSH depletion and increased ROS generation"/>
   <result pre="] demonstrated that the mechanism of action of thymoquinone on" exact="cancer" post="cells involves apoptosis and cell cycle arrest. Apoptosis and"/>
   <result pre="of Hassan and collaborators [ 75 ] in the HepG2" exact="hepatocellular carcinoma" post="cell line and in the studies of Gali-Muhtasib and"/>
   <result pre="] showed that thymoquinone produced cytotoxic effects on Neuro-2a mouse" exact="neuroblastoma" post="cells through caspase 3 activation, with downregulation of XIAP."/>
   <result pre="Abusnina and collaborators [ 79 ] demonstrated that thymoquinone induces" exact="acute lymphoblastic leukemia" post="cell apoptosis. Thymoquinone also has potential as a novel"/>
   <result pre="and collaborators [ 79 ] demonstrated that thymoquinone induces acute" exact="lymphoblastic leukemia" post="cell apoptosis. Thymoquinone also has potential as a novel"/>
   <result pre="collaborators [ 79 ] demonstrated that thymoquinone induces acute lymphoblastic" exact="leukemia" post="cell apoptosis. Thymoquinone also has potential as a novel"/>
   <result pre="Thymoquinone also has potential as a novel therapeutic agent against" exact="pancreatic cancer." post="Torres and collaborators [ 80 ] demonstrated that thymoquinone"/>
   <result pre="[ 80 ] demonstrated that thymoquinone downregulated MUC4 expression in" exact="pancreatic cancer" post="cells and induced apoptosis by two different pathways. The"/>
   <result pre="80 ] demonstrated that thymoquinone downregulated MUC4 expression in pancreatic" exact="cancer" post="cells and induced apoptosis by two different pathways. The"/>
   <result pre="thymoquinone upregulated PTEN expression and induced apoptosis in doxorubicin-resistant human" exact="breast cancer" post="cells. This study suggested that thymoquinone may not be"/>
   <result pre="upregulated PTEN expression and induced apoptosis in doxorubicin-resistant human breast" exact="cancer" post="cells. This study suggested that thymoquinone may not be"/>
   <result pre="87 ] also analyzed thymoquinone analogs with potential cytotoxicity against" exact="cancer" post="cells. El-Najjar and collaborators [ 88 ] showed that"/>
   <result pre="mice liver. Thymoquinone inhibited proliferation, induced apoptosis, and chemosensitized human" exact="multiple myeloma" post="cells through suppression of the signal transducer and activator"/>
   <result pre="proliferation, induced apoptosis, and chemosensitized human multiple myeloma cells through" exact="suppression" post="of the signal transducer and activator of transcription 3"/>
   <result pre="through translation inhibition of Cyclin D1 and induced apoptosis in" exact="breast cancer" post="cells. Effenberger-Neidnicht and collaborators [ 93 ] showed that"/>
   <result pre="translation inhibition of Cyclin D1 and induced apoptosis in breast" exact="cancer" post="cells. Effenberger-Neidnicht and collaborators [ 93 ] showed that"/>
   <result pre="that thymoquinone boosted the anticancer effects of doxorubicin in certain" exact="cancer" post="cell. Tundis and collaborators [ 94 ] demonstrated the"/>
   <result pre="PPAR- γ pathway in the anticancer activity of thymoquinone in" exact="breast cancer" post="cells. Thymoquinone enhances survival and activity of antigen-specific CD8-positive"/>
   <result pre="γ pathway in the anticancer activity of thymoquinone in breast" exact="cancer" post="cells. Thymoquinone enhances survival and activity of antigen-specific CD8-positive"/>
   <result pre="in vitro, a result that can be useful in the" exact="cancer" post="therapy [ 95 ]. Exposure of cancer cells derived"/>
   <result pre="useful in the cancer therapy [ 95 ]. Exposure of" exact="cancer" post="cells derived from lung, liver, colon, melanoma, and breast"/>
   <result pre="mitochondrial proapoptotic pathways. Thymoquinone inhibited the invasive potential of various" exact="cancer" post="cells. Moreover, thymoquinone synergizes with cisplatin to inhibit cellular"/>
   <result pre="through activation of GSK-3 β. Thymoquinone also induced apoptosis in" exact="oral cancer" post="cells through P38 β inhibition [ 98 ]. Odeh"/>
   <result pre="activation of GSK-3 β. Thymoquinone also induced apoptosis in oral" exact="cancer" post="cells through P38 β inhibition [ 98 ]. Odeh"/>
   <result pre="thymoquinone induced degradation of α- and β-tubulin proteins in human" exact="cancer" post="cells without affecting their levels in normal human fibroblasts."/>
   <result pre="them, the acyclic monoterpene, myrcene, exhibited significant cytotoxicity against P388" exact="leukemia" post="cell. 1.15. Sobrerol Sobrerol showed anticarcinogenic activity during the"/>
   <result pre="Limonene Studies have demonstrated the antitumorigenic effects of limonene against" exact="pancreatic cancer" post="and breast cancer [ 105 ]. Limonene showed antioxidant"/>
   <result pre="Studies have demonstrated the antitumorigenic effects of limonene against pancreatic" exact="cancer" post="and breast cancer [ 105 ]. Limonene showed antioxidant"/>
   <result pre="demonstrated the antitumorigenic effects of limonene against pancreatic cancer and" exact="breast cancer" post="[ 105 ]. Limonene showed antioxidant and radical scavenging"/>
   <result pre="the antitumorigenic effects of limonene against pancreatic cancer and breast" exact="cancer" post="[ 105 ]. Limonene showed antioxidant and radical scavenging"/>
   <result pre="was mediated by a caspase-dependent mitochondrial death pathway in human" exact="leukemia" post="cells. Furthermore, d-limonene induced apoptosis in HL-60 cells through"/>
   <result pre="affinity with the receptor and thus reduced the possibility of" exact="cancer" post="growth. Chen and collaborators [ 113 ] suggested that"/>
   <result pre="and acted as an antiangiogenic with a preventative effect on" exact="colon cancer." post="Limonene also showed a selective antiproliferative action on tumor"/>
   <result pre="limonene may have potential as a chemopreventive agent against aflatoxin-induced" exact="liver cancer." post="D-Limonene inhibited the development of colonic aberrant crypt foci"/>
   <result pre="doses and may be an effective chemotherapeutic agent for human" exact="pancreatic cancer." post="The antitumor activity of perillyl alcohol against pancreatic cancers"/>
   <result pre="studies to evaluate the cytotoxicity mechanisms of perillyl alcohol against" exact="pancreatic cancer" post="cells were conducted by Lebedeva and collaborators [ 131"/>
   <result pre="to evaluate the cytotoxicity mechanisms of perillyl alcohol against pancreatic" exact="cancer" post="cells were conducted by Lebedeva and collaborators [ 131"/>
   <result pre="] demonstrated that the perillyl alcohol inhibited telomerase activity in" exact="prostate cancer" post="cells. Perillyl alcohol in combination with STI571 enhances the"/>
   <result pre="demonstrated that the perillyl alcohol inhibited telomerase activity in prostate" exact="cancer" post="cells. Perillyl alcohol in combination with STI571 enhances the"/>
   <result pre="induce apoptosis in K562 cells [ 133 ]. In bcr/abl-transformed" exact="leukemia" post="cells perillyl alcohol induced c-myc-dependent apoptosis [ 134 ]."/>
   <result pre="activity were evidenced. Other studies revealed that perillyl alcohol sensitized" exact="cancer" post="cells to cisplatin and radiation in a dose-dependent manner."/>
   <result pre="] demonstrated induction of AP-1 activity by perillyl alcohol in" exact="breast cancer" post="cells. Ahn and collaborators [ 141 ] verified that"/>
   <result pre="demonstrated induction of AP-1 activity by perillyl alcohol in breast" exact="cancer" post="cells. Ahn and collaborators [ 141 ] verified that"/>
   <result pre="[ 141 ] verified that cytotoxicity of perillyl alcohol against" exact="cancer" post="cells is potentiated by hyperthermia. Ren and Gould ["/>
   <result pre="have potential for use as a chemopreventive agent against aflatoxin-induced" exact="liver cancer." post="Balassiano and collaborators [ 144 ] observed the effects"/>
   <result pre="chemoprevention by perillyl alcohol, coupled with viral gene therapy, reduced" exact="pancreatic cancer" post="pathogenesis. Perilla aldehyde is a major intermediary metabolite of"/>
   <result pre="by perillyl alcohol, coupled with viral gene therapy, reduced pancreatic" exact="cancer" post="pathogenesis. Perilla aldehyde is a major intermediary metabolite of"/>
   <result pre="phase II trial of perillyl alcohol in patients with metastatic" exact="colorectal cancer" post="was conducted by Meadows and collaborators [ 157 ],"/>
   <result pre="II trial of perillyl alcohol in patients with metastatic colorectal" exact="cancer" post="was conducted by Meadows and collaborators [ 157 ],"/>
   <result pre="Terpinen-4-ol also induced necrosis and cell cycle arrest in murine" exact="cancer" post="cell lines [ 163 ]. 1.23. Citral Citral is"/>
   <result pre="163 ]. 1.23. Citral Citral is cytotoxic against P388 mouse" exact="leukemia" post="[ 164 ], HeLa [ 165 ], Ishikawa, and"/>
   <result pre="[ 164 ], HeLa [ 165 ], Ishikawa, and ECC-1" exact="cancer" post="cells [ 166 ]. Xia and collaborators [ 167"/>
   <result pre="potential of beta-pinene was investigated in MCF-7, A375, and HepG2" exact="cancer" post="cells [ 94 ] and in other different tumor"/>
   <result pre="[ 175 ] demonstrated that this monoterpene sensitized human colonic" exact="cancer" post="cells to 5-Fluorouracil treatment in vitro. In a later"/>
   <result pre="the activity of HMG-CoA reductase, which reduced the possibility of" exact="cancer" post="growth [ 112 ]. Geraniol also inhibited growth and"/>
   <result pre="]. Geraniol also inhibited growth and polyamine biosynthesis in human" exact="colon cancer" post="cells [ 179 ]. Zheng and collaborators [ 122"/>
   <result pre="Geraniol also inhibited growth and polyamine biosynthesis in human colon" exact="cancer" post="cells [ 179 ]. Zheng and collaborators [ 122"/>
   <result pre="H520, H661, OSCC-1/KMC, J82 [ 184 ], human leukemia, and" exact="lymphoma" post="cell lines [ 185 ], amelanotic melanoma C32 cells,"/>
   <result pre="], human leukemia, and lymphoma cell lines [ 185 ]," exact="amelanotic melanoma" post="C32 cells, and renal cell adenocarcinoma cells [ 186"/>
   <result pre="that linalool preferentially induced robust apoptosis of a variety of" exact="leukemia" post="cells by upregulation of p53 and cyclin-dependent kinase inhibitors."/>
   <result pre="thymol on peripheral blood mononuclear cell PBMC and acute promyelotic" exact="cancer" post="cell line HL-60 Chemico-Biological Interactions 2011 193 1 97"/>
   <result pre="S. B. Larsson R. L. Gali-Muhtasib A. U H. Anti-colon" exact="cancer" post="components from Lebanese sage ( Salvia libanotica) essential oil:"/>
   <result pre="S. Ip S. W. Chung J. G. (−)-Menthol inhibits WEHI-3" exact="leukemia" post="cells in vitro and in vivo In Vivo 2007"/>
   <result pre="alpha and beta and promotes NF-kappaB expression in human gastric" exact="cancer" post="SNU-5 cells Anticancer Res 2005 25 2069 2074 [16158947]"/>
   <result pre="D. Meng Z. Menthol inhibits the proliferation and motility of" exact="prostate cancer" post="DU145 cells Pathology Oncology Research 2005 18 4 903"/>
   <result pre="Meng Z. Menthol inhibits the proliferation and motility of prostate" exact="cancer" post="DU145 cells Pathology Oncology Research 2005 18 4 903"/>
   <result pre="induces cell death via the TRPM8 channel in the human" exact="bladder cancer" post="cell line T24 Oncology 2009 77 6 335 341"/>
   <result pre="cell death via the TRPM8 channel in the human bladder" exact="cancer" post="cell line T24 Oncology 2009 77 6 335 341"/>
   <result pre="Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human" exact="hepatocellular carcinoma" post="cells by enhancement of cellular uptake and activationof ROS-mediated"/>
   <result pre="Y. Z. Anti-proliferative and pro-apoptotic effect of carvacrol on human" exact="hepatocellular carcinoma" post="cell line HepG-2 Cytotechnology 2012 64 43 51 [10.1007/s10616-011-9389-y]"/>
   <result pre="K. M. Anti-proliferative effects of carvacrol on a human metastatic" exact="breast cancer" post="cell line, MDA-MB 231 Phytomedicine 2010 17 8-9 581"/>
   <result pre="M. Anti-proliferative effects of carvacrol on a human metastatic breast" exact="cancer" post="cell line, MDA-MB 231 Phytomedicine 2010 17 8-9 581"/>
   <result pre="J. Devaki T. Potential preventive effect of carvacrol against diethylnitrosamine-induced" exact="hepatocellular carcinoma" post="in rats Molecular and Cellular Biochemistry 2012 360 51"/>
   <result pre="Priyadharsini J. Jayaraman G. Anti-cancer effects of thymoquinone in mouse" exact="neuroblastoma" post="(Neuro-2a) cells through caspase-3 activation with down-regulation of XIAP"/>
   <result pre="of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human" exact="cancer" post="cell lines Anticancer Research 2005 25 2199 2204 [16158964]"/>
   <result pre="activity of gemcitabine and oxaliplatin is augmented by thymoquinone in" exact="pancreatic cancer" post="Cancer Research 2009 69 5575 5583 [10.1158/0008-5472.CAN-08-4235] [19549912] 56"/>
   <result pre="of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic" exact="cancer" post="Cancer Research 2009 69 5575 5583 [10.1158/0008-5472.CAN-08-4235] [19549912] 56"/>
   <result pre="nuclear factor- κ B activation pathway by thymoquinone: role in" exact="suppression" post="of antiapoptotic gene products and enhancement of apoptosis Molecular"/>
   <result pre="stress response pathway sensor CHEK1 and contributes to apoptosis in" exact="colorectal cancer" post="cells Cancer Research 2008 68 5609 5618 [10.1158/0008-5472.CAN-08-0884] [18632613]"/>
   <result pre="response pathway sensor CHEK1 and contributes to apoptosis in colorectal" exact="cancer" post="cells Cancer Research 2008 68 5609 5618 [10.1158/0008-5472.CAN-08-0884] [18632613]"/>
   <result pre="Sethi G. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human" exact="multiple myeloma" post="cells through suppression of signal transducer and activator of"/>
   <result pre="proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through" exact="suppression" post="of signal transducer and activator of transcription 3 activation"/>
   <result pre="A. El-Din A. M. G. Antitumor activity of thymoquinone against" exact="fibrosarcoma" post="tumorigenesis Cancer Molecular Biology 2000 7 3 1515 1526"/>
   <result pre="Gamal E. A. M. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced" exact="fibrosarcoma" post="tumorigenesis Cancer Detection and Prevention 2001 25 362 368"/>
   <result pre="of p53 augments thymoquinone-induced apoptosis and caspase activation in human" exact="osteosarcoma" post="cells Cancer Biology &amp;amp; Therapy 2007 6 160 169"/>
   <result pre="X. Lin Z. Q. Chen Q. Yu. Antitumorandanti-angiogenesis effects ofthymoquinoneon" exact="osteosarcoma" post="through the NF- κB pathway Oncology Reports 2013 29"/>
   <result pre="through activation of caspase-8 and mitochondrial events in p53-null myeloblastic" exact="leukemia" post="HL-60 cells International Journal of Cancer 2005 117 409"/>
   <result pre="on molecular mechanisms of growth inhibitory effects of thymoquinone against" exact="prostate cancer" post="cells: role of reactive oxygen species Experimental Biology and"/>
   <result pre="molecular mechanisms of growth inhibitory effects of thymoquinone against prostate" exact="cancer" post="cells: role of reactive oxygen species Experimental Biology and"/>
   <result pre="In vitro inhibition of growth and induction of apoptosis in" exact="cancer" post="cell lines by thymoquinone International Journal of Oncology 2003"/>
   <result pre="A. Abu-Bedair F. A. In vitro challenge using thymoquinone on" exact="hepatocellular carcinoma" post="(HepG2) cell line Iranian Journal of Pharmaceutical Research 2008"/>
   <result pre="the key event of p73 and UHRF1 deregulation in thymoquinone-induced" exact="acute lymphoblastic leukemia" post="cell apoptosis Cellular Signalling 2011 23 152 160 [20807569]"/>
   <result pre="key event of p73 and UHRF1 deregulation in thymoquinone-induced acute" exact="lymphoblastic leukemia" post="cell apoptosis Cellular Signalling 2011 23 152 160 [20807569]"/>
   <result pre="event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic" exact="leukemia" post="cell apoptosis Cellular Signalling 2011 23 152 160 [20807569]"/>
   <result pre="Effects of thymoquinone in the expression of mucin 4 in" exact="pancreatic cancer" post="cells: implications for the development of novel cancer therapies"/>
   <result pre="of thymoquinone in the expression of mucin 4 in pancreatic" exact="cancer" post="cells: implications for the development of novel cancer therapies"/>
   <result pre="in pancreatic cancer cells: implications for the development of novel" exact="cancer" post="therapies Molecular Cancer Therapeutics 2010 9 1419 1431 [20423995]"/>
   <result pre="Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human" exact="breast cancer" post="cells Mutation Research 2011 706 1-2 28 35 [21040738]"/>
   <result pre="up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast" exact="cancer" post="cells Mutation Research 2011 706 1-2 28 35 [21040738]"/>
   <result pre="M. Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent" exact="colorectal cancer" post="cells Experimental and Therapeutic Medicine 2010 1 369 375"/>
   <result pre="Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal" exact="cancer" post="cells Experimental and Therapeutic Medicine 2010 1 369 375"/>
   <result pre="M. Structure-activity studies on therapeutic potential of thymoquinone analogs in" exact="pancreatic cancer" post="Pharmaceutical Research 2010 27 1146 1158 [10.1007/s11095-010-0145-3] [20422266] 87"/>
   <result pre="Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic" exact="cancer" post="Pharmaceutical Research 2010 27 1146 1158 [10.1007/s11095-010-0145-3] [20422266] 87"/>
   <result pre="the Nigella sativa seed-oil constituent thymoquinone with enhanced efficacy in" exact="cancer" post="cells Chemistry &amp;amp; Biodiversity 2010 7 129 139 [20087986]"/>
   <result pre="through translation inhibition of cyclin D1 and induces apoptosis in" exact="breast cancer" post="cells Life Sciences 2013 93 783 790 [10.1016/j.lfs.2013.09.009] [24044882]"/>
   <result pre="translation inhibition of cyclin D1 and induces apoptosis in breast" exact="cancer" post="cells Life Sciences 2013 93 783 790 [10.1016/j.lfs.2013.09.009] [24044882]"/>
   <result pre="vitro cytotoxic effects of Senecio stabianus Lacaita (Asteraceae) on human" exact="cancer" post="cell lines Natural Products Research 2009 23 18 1707"/>
   <result pre="Adem A. Thymoquinoneas an anticancer agent: evidence from inhibition of" exact="cancer" post="cells viability and invasion in vitro and tumor growth"/>
   <result pre="liposomes: a study of loading efficiency and biological activity towards" exact="breast cancer" post="Drug Delivery 2012 19 371 377 [10.3109/10717544.2012.727500] [23043626] 100"/>
   <result pre="a study of loading efficiency and biological activity towards breast" exact="cancer" post="Drug Delivery 2012 19 371 377 [10.3109/10717544.2012.727500] [23043626] 100"/>
   <result pre="induces degradation of α and β tubulin proteins in human" exact="cancer" post="cells without affecting their level in normal human fibroblasts"/>
   <result pre="Glombitza K. W. Cytotoxicity and in vitro effects on human" exact="cancer" post="cell lines of volatiles of Apium graveolens var. filicinum"/>
   <result pre="Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and" exact="breast cancer" post="Dietary Phytochemicals in Cancer Prevention and Treatment 1996 401"/>
   <result pre="effects of limonene and perillyl alcohol against pancreatic and breast" exact="cancer" post="Dietary Phytochemicals in Cancer Prevention and Treatment 1996 401"/>
   <result pre="is mediated by a caspase-dependent mitochondrial death pathway in human" exact="leukemia" post="cells Leukemia &amp;amp; Lymphoma 2006 47 2617 2624 [17169807]"/>
   <result pre="limonene interaction with 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase for their role as" exact="cancer" post="chemo-preventive agents Journal of Proteomics &amp;amp; Bioinformatics 2009 2"/>
   <result pre="B. S. P. Citrus monoterpenes: potential source of phytochemicals for" exact="cancer" post="prevention Emerging Trends in Dietary Components for Preventing and"/>
   <result pre="Tilia x viridis flower extract on the proliferation of a" exact="lymphoma" post="cell line and on normal murine lymphocytes: contribution of"/>
   <result pre="acid induced cell cycle arrest and apoptosis in non-small cell" exact="lung cancer" post="cells Cancer Letters 2007 257 216 226 [17888568] 126"/>
   <result pre="induced cell cycle arrest and apoptosis in non-small cell lung" exact="cancer" post="cells Cancer Letters 2007 257 216 226 [17888568] 126"/>
   <result pre="Wang Robert C. Elegbede A. Monoterpenes enhanced the sensitivity of" exact="head and neck cancer" post="cells to radiation treatment in vitro Anticancer Research 2004"/>
   <result pre="Elegbede A. Monoterpenes enhanced the sensitivity of head and neck" exact="cancer" post="cells to radiation treatment in vitro Anticancer Research 2004"/>
   <result pre="J. H. Ayoubi S. A. Crowell P. L. Chemotherapy of" exact="pancreatic cancer" post="with the monoterpene perillyl alcohol Cancer Letters 1995 96"/>
   <result pre="H. Ayoubi S. A. Crowell P. L. Chemotherapy of pancreatic" exact="cancer" post="with the monoterpene perillyl alcohol Cancer Letters 1995 96"/>
   <result pre="S. L. Sen S. E. Crowell P. L. Inhibition of" exact="pancreatic cancer" post="growth by the dietary isoprenoids farnesol and geraniol Lipids"/>
   <result pre="L. Sen S. E. Crowell P. L. Inhibition of pancreatic" exact="cancer" post="growth by the dietary isoprenoids farnesol and geraniol Lipids"/>
   <result pre="Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces" exact="pancreatic cancer" post="pathogenesis Molecular Cancer Therapeutics 2008 7 2042 2050 [18645014]"/>
   <result pre="by perillyl alcohol coupled with viral gene therapy reduces pancreatic" exact="cancer" post="pathogenesis Molecular Cancer Therapeutics 2008 7 2042 2050 [18645014]"/>
   <result pre="Clark S. S. Perillyl alcohol Iinduces c-Myc-dependent apoptosis in Bcr/Abl-transformed" exact="leukemia" post="cells Oncology 2006 70 13 18 [16439861] 135 Loutrari"/>
   <result pre="M. N. Induction of AP-1 activity by perillyl alcohol in" exact="breast cancer" post="cells Carcinogenesis 1999 20 1957 1961 [10506111] 141 Ahn"/>
   <result pre="N. Induction of AP-1 activity by perillyl alcohol in breast" exact="cancer" post="cells Carcinogenesis 1999 20 1957 1961 [10506111] 141 Ahn"/>
   <result pre="C. W. Park H. J. Cytotoxicity of perillyl alcohol against" exact="cancer" post="cells is potentiated by hyperthermia International Journal of Radiation"/>
   <result pre="P. Athar M. Fisher P. B. Mechanism of in vitro" exact="pancreatic cancer" post="cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl"/>
   <result pre="Athar M. Fisher P. B. Mechanism of in vitro pancreatic" exact="cancer" post="cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl"/>
   <result pre="Howard S. P. Perillyl alcohol as a radio-/chemosensitizer in malignant" exact="glioma" post="The Journal of Biological Chemistry 2003 278 35968 35978"/>
   <result pre="Phase II trial of perillyl alcohol in patients with metastatic" exact="colorectal cancer" post="International Journal of Gastrointestinal Cancer 2002 32 2-3 125"/>
   <result pre="II trial of perillyl alcohol in patients with metastatic colorectal" exact="cancer" post="International Journal of Gastrointestinal Cancer 2002 32 2-3 125"/>
   <result pre="F. Induction of necrosis and cell cycle arrest in murine" exact="cancer" post="cell lines by Melaleuca alternifolia (tea tree) oil and"/>
   <result pre="isolated from the essential oil of Cymbopogon citratus against P388" exact="leukemia" post="cells Current Science 1997 73 22 24 165 Wright"/>
   <result pre="Kele M. S. Potential anticancer activity of carvone in N2a" exact="neuroblastoma" post="cell line Toxicology and Industrial Health 2013 170 Chaverri"/>
   <result pre="Geraniol, a component of plant essential oils, sensitizes human colonic" exact="cancer" post="cells to 5-Fluorouracil treatment Journal of Pharmacology and Experimental"/>
   <result pre="plant essential oils, inhibits growth and polyamine biosynthesis in human" exact="colon cancer" post="cells Journal of Pharmacology and Experimental Therapeutics 2001 298"/>
   <result pre="essential oils, inhibits growth and polyamine biosynthesis in human colon" exact="cancer" post="cells Journal of Pharmacology and Experimental Therapeutics 2001 298"/>
   <result pre="effects of minor dietary constituents in common foods on human" exact="cancer" post="cells Bioscience, Biotechnology, and Biochemistry 2007 71 1500 1504"/>
   <result pre="oils and their major constituents in human renal adenocarcinoma and" exact="amelanotic melanoma" post="cells Cell Proliferation 2008 41 1002 1012 [19040575] 187"/>
   <result pre="R. Linalool preferentially induces robust apoptosis of a variety of" exact="leukemia" post="cells via upregulating p53 and cyclin-dependent kinase inhibitors Toxicology"/>
   <result pre="( Lindera umbellata) essential oil-induced apoptosis and differentiation in human" exact="leukemia" post="HL-60 cells Experimental and Therapeutic Medicine 2012 3 1"/>
   <result pre="P. Tan K. H. B. Anticancer activity of thymoquinone in" exact="breast cancer" post="cells: possible involvement of PPAR- γ pathway Biochemical Pharmacology"/>
   <result pre="Tan K. H. B. Anticancer activity of thymoquinone in breast" exact="cancer" post="cells: possible involvement of PPAR- γ pathway Biochemical Pharmacology"/>
   <result pre="arrest; induction of apoptosis)             Human" exact="colon cancer" post="cell lines HCT-116 (p53+/+)           "/>
   <result pre="induction of apoptosis)             Human colon" exact="cancer" post="cell lines HCT-116 (p53+/+)           "/>
   <result pre="        10–30% ∗,a  [ 13 ]  Human" exact="colon cancer" post="cell lines HCT-116 (p53−/−)          10–30%"/>
   <result pre="      10–30% ∗,a  [ 13 ]  Human colon" exact="cancer" post="cell lines HCT-116 (p53−/−)          10–30%"/>
   <result pre="Active (cell cycle arrest; induction of apoptosis)     Human" exact="colon cancer" post="cell lines HCT-116 (p53+/+)     10–30% ∗,a   ["/>
   <result pre="(cell cycle arrest; induction of apoptosis)     Human colon" exact="cancer" post="cell lines HCT-116 (p53+/+)     10–30% ∗,a   ["/>
   <result pre="HCT-116 (p53+/+)     10–30% ∗,a   [ 13 ] Human" exact="colon cancer" post="cell lines HCT-116 (p53−/−)      10–30% ∗,a   "/>
   <result pre="(p53+/+)     10–30% ∗,a   [ 13 ] Human colon" exact="cancer" post="cell lines HCT-116 (p53−/−)      10–30% ∗,a   "/>
   <result pre="HeLa (epithelioid carcinomic cell line) ND  Active (ND) MOLT-4 (human" exact="lymphoblastic leukemia" post="T-cell line) ND [ 14 ]   K-562 (human"/>
   <result pre="(epithelioid carcinomic cell line) ND  Active (ND) MOLT-4 (human lymphoblastic" exact="leukemia" post="T-cell line) ND [ 14 ]   K-562 (human"/>
   <result pre="line) ND [ 14 ]   K-562 (human chronic myelogenous" exact="leukemia" post="cell line) ND    CTVR-1 (early B-cell line from"/>
   <result pre="Active (ND)           K-562 (human chronic myelogenous" exact="leukemia" post="cell line)          56.15  µg/mL    "/>
   <result pre="the NF- κB pathway)         Small cell" exact="lung carcinoma" post="         0.26 mM         "/>
   <result pre="16 ]          Active (ND) Mouse P388" exact="leukemia" post="cell 34–54  µg/mL∗ [ 17 ]     Active"/>
   <result pre="CD11b markers of macrophages and granulocytes precursors)     Murine" exact="leukemia" post="WEHI-3 cells ( in vitro) Murine leukemia WEHI-3 cells"/>
   <result pre="    Murine leukemia WEHI-3 cells ( in vitro) Murine" exact="leukemia" post="WEHI-3 cells ( in vivo)     ND 1"/>
   <result pre="Active (mitochondrial membrane depolarization via the TRPM8 channel) T24 (Human" exact="bladder cancer" post="cell line) ND [ 22 ] Active (agonist of"/>
   <result pre="(mitochondrial membrane depolarization via the TRPM8 channel) T24 (Human bladder" exact="cancer" post="cell line) ND [ 22 ] Active (agonist of"/>
   <result pre="  Active (ND)            KATO-III (human" exact="stomach cancer" post="cell line)            67% b"/>
   <result pre="Active (ND)            KATO-III (human stomach" exact="cancer" post="cell line)            67% b"/>
   <result pre="   Active (ND)            KATO-III (human" exact="stomach cancer" post="cell line)            86% b"/>
   <result pre="Active (ND)            KATO-III (human stomach" exact="cancer" post="cell line)            86% b"/>
   <result pre="b    Active (ND)         KATO-III (human" exact="stomach cancer" post="cell line)         85% b ["/>
   <result pre="  Active (ND)         KATO-III (human stomach" exact="cancer" post="cell line)         85% b ["/>
   <result pre="line)     ND   Active (ND) HL60 (acute promyelocytic" exact="cancer" post="cell line)  ND [ 28 ]   MDA-MB-231 (Human"/>
   <result pre="cell line)  ND [ 28 ]   MDA-MB-231 (Human metastatic" exact="breast cancer" post="cell line)  ND   Active (ND) HL-60 (acute promyelocytic"/>
   <result pre="line)  ND [ 28 ]   MDA-MB-231 (Human metastatic breast" exact="cancer" post="cell line)  ND   Active (ND) HL-60 (acute promyelocytic"/>
   <result pre="cancer cell line)  ND   Active (ND) HL-60 (acute promyelocytic" exact="cancer" post="cell line) 6.3  µg/mL [ 29 ] HCT-8 (ileocecal"/>
   <result pre="vivo) 10 or 20 mg/kg [ 29 ] Active (ND) Mouse" exact="leukemia" post="P388 cell line ND [ 30 ]   P815"/>
   <result pre="36 ]  Active (induction of apoptosis) MDA-MB 231 (human metastatic" exact="breast cancer" post="cell line)  100  μM [ 37 ]   HepG2"/>
   <result pre="]  Active (induction of apoptosis) MDA-MB 231 (human metastatic breast" exact="cancer" post="cell line)  100  μM [ 37 ]   HepG2"/>
   <result pre="malignant cell line)  ND [ 32 ]   K562 (erythromyeloblastoid" exact="leukemia" post="cell line)  150–200  μM [ 33 ] Active (ND)"/>
   <result pre="  [ 42 ]       Active (ND) Mouse" exact="leukemia" post="P388 cell line 1.1  µg/mL [ 44 ]  "/>
   <result pre="      Active (ND)           Mouse" exact="leukemia" post="P388 cell line         ND  "/>
   <result pre="    Active (cell cycle arrest; induction of apoptosis) K562 (erythromyeloblastoid" exact="leukemia" post="cell line)   ND  [ 9 ]        "/>
   <result pre="Caco-2 (colon malignant cell line)  700  μM  Active (ND) Mouse" exact="leukemia" post="P388 cell line  ND  [ 30 ] Active (ND)"/>
   <result pre="P388 cell line  ND  [ 30 ] Active (ND) Mouse" exact="leukemia" post="P388 cell line 0.80  µg/mL [ 44 ]  "/>
   <result pre="malignant cell line)  ND [ 32 ]   K562 (erythromyeloblastoid" exact="leukemia" post="cell line)  400–500  µM  [ 33 ] Active (cell"/>
   <result pre="Active (cell cycle arrest; induction of apoptosis) HL-60 (acute promyelocytic" exact="cancer" post="cell line) ND [ 12 ] Active (ND) HepG2"/>
   <result pre="cell line) 60.0–67.9  µM∗      SF-539 (central nervous system" exact="cancer" post="cell line) ND     PC-3 (prostate cancer cell"/>
   <result pre="nervous system cancer cell line) ND     PC-3 (prostate" exact="cancer" post="cell line) ND   Active (ND) M-14 (melanoma) ND"/>
   <result pre="(ND) M-14 (melanoma) ND [ 48 ]   OVCAR-5 (ovarian" exact="cancer" post="cell line) ND     MCF-7 (breast adenocarcinoma cell"/>
   <result pre="Active (proteasome inhibition and induction of apoptosis) U87 MG (malignant" exact="glioma" post="cells)  T98G (malignant glioma cells) 61.46–77.73  µM∗  35.83–47.08  µM∗"/>
   <result pre="induction of apoptosis) U87 MG (malignant glioma cells)  T98G (malignant" exact="glioma" post="cells) 61.46–77.73  µM∗  35.83–47.08  µM∗ [ 51 ]   Active"/>
   <result pre="[ 51 ]   Active (induction of apoptosis)  NCI-H460 (nonsmall cell" exact="lung cancer" post="cell line)  NCI-H146 (small cell lung cancer cell line)"/>
   <result pre="51 ]   Active (induction of apoptosis)  NCI-H460 (nonsmall cell lung" exact="cancer" post="cell line)  NCI-H146 (small cell lung cancer cell line)"/>
   <result pre=" NCI-H460 (nonsmall cell lung cancer cell line)  NCI-H146 (small cell" exact="lung cancer" post="cell line) ND  ND [ 52 ]  Active (downregulation"/>
   <result pre="(nonsmall cell lung cancer cell line)  NCI-H146 (small cell lung" exact="cancer" post="cell line) ND  ND [ 52 ]  Active (downregulation"/>
   <result pre="stress response pathway sensor CHEK1 and induction of apoptosis) Human" exact="colon cancer" post="cell lines HCT-116 (p53+/+ and p53−/−) ND  [ 57"/>
   <result pre="response pathway sensor CHEK1 and induction of apoptosis) Human colon" exact="cancer" post="cell lines HCT-116 (p53+/+ and p53−/−) ND  [ 57"/>
   <result pre="54 ]  Active (downregulation of NF- κB) Orthotopic model of" exact="pancreatic cancer" post="( in vitro)  Orthotopic model of pancreatic cancer ("/>
   <result pre="]  Active (downregulation of NF- κB) Orthotopic model of pancreatic" exact="cancer" post="( in vitro)  Orthotopic model of pancreatic cancer ("/>
   <result pre="model of pancreatic cancer ( in vitro)  Orthotopic model of" exact="pancreatic cancer" post="( in vivo) ND   3 mg/mouse [ 55 ]  "/>
   <result pre="of pancreatic cancer ( in vitro)  Orthotopic model of pancreatic" exact="cancer" post="( in vivo) ND   3 mg/mouse [ 55 ]  "/>
   <result pre="  Active (induction of p53-independent apoptosis)       Human" exact="osteosarcoma" post="cells (p53-null MG63 cells)  (p53-mutant MNNG/HOS cells)    "/>
   <result pre="species and activation of ERK and JNK signaling) Caco-2 (human" exact="colon cancer" post="cell) 12.5–15.0  µM∗  [ 65 ] HCT-116 (human colon"/>
   <result pre="and activation of ERK and JNK signaling) Caco-2 (human colon" exact="cancer" post="cell) 12.5–15.0  µM∗  [ 65 ] HCT-116 (human colon"/>
   <result pre="colon cancer cell) 12.5–15.0  µM∗  [ 65 ] HCT-116 (human" exact="colon cancer" post="cell)  14–30  µM∗  LoVo (human colon cancer cell)  28–38 "/>
   <result pre="cancer cell) 12.5–15.0  µM∗  [ 65 ] HCT-116 (human colon" exact="cancer" post="cell)  14–30  µM∗  LoVo (human colon cancer cell)  28–38 "/>
   <result pre="] HCT-116 (human colon cancer cell)  14–30  µM∗  LoVo (human" exact="colon cancer" post="cell)  28–38  µM∗  DLD-1 (human colon cancer cell) 23–42 "/>
   <result pre="HCT-116 (human colon cancer cell)  14–30  µM∗  LoVo (human colon" exact="cancer" post="cell)  28–38  µM∗  DLD-1 (human colon cancer cell) 23–42 "/>
   <result pre="µM∗  LoVo (human colon cancer cell)  28–38  µM∗  DLD-1 (human" exact="colon cancer" post="cell) 23–42  µM∗  HT-29 (human colon cancer cell) 110 "/>
   <result pre="LoVo (human colon cancer cell)  28–38  µM∗  DLD-1 (human colon" exact="cancer" post="cell) 23–42  µM∗  HT-29 (human colon cancer cell) 110 "/>
   <result pre="µM∗  DLD-1 (human colon cancer cell) 23–42  µM∗  HT-29 (human" exact="colon cancer" post="cell) 110  µM Active (binding to bovine serum albumin)"/>
   <result pre="DLD-1 (human colon cancer cell) 23–42  µM∗  HT-29 (human colon" exact="cancer" post="cell) 110  µM Active (binding to bovine serum albumin)"/>
   <result pre="110  µM Active (binding to bovine serum albumin) DLD-1 (human" exact="colon cancer" post="cell) ND [ 88 ] HCT-116 (human colon cancer"/>
   <result pre="µM Active (binding to bovine serum albumin) DLD-1 (human colon" exact="cancer" post="cell) ND [ 88 ] HCT-116 (human colon cancer"/>
   <result pre="(human colon cancer cell) ND [ 88 ] HCT-116 (human" exact="colon cancer" post="cell)  ND Active (ND) A549 (human nonsmall cell lung"/>
   <result pre="colon cancer cell) ND [ 88 ] HCT-116 (human colon" exact="cancer" post="cell)  ND Active (ND) A549 (human nonsmall cell lung"/>
   <result pre="colon cancer cell)  ND Active (ND) A549 (human nonsmall cell" exact="lung cancer" post="(NSCLC) cell line)  ND  [ 67 ] Active (antioxidant"/>
   <result pre="cancer cell)  ND Active (ND) A549 (human nonsmall cell lung" exact="cancer" post="(NSCLC) cell line)  ND  [ 67 ] Active (antioxidant"/>
   <result pre="line)  ND  [ 67 ] Active (antioxidant activity)  ES-2 (ovarian" exact="cancer" post="cell line)  ND [ 66 ] Active (prooxidant cytotoxic"/>
   <result pre="line)  ND [ 66 ] Active (prooxidant cytotoxic mechanism) Prostate" exact="cancer" post="cell lines  ND [ 68 ] Active (ND) 66"/>
   <result pre="[ 69 ] Active (disruption in cell-cycle checkpoints) LNCaP (prostate" exact="cancer" post="cell line)  LNCaP (prostate cancer cell line )  ND ND"/>
   <result pre="in cell-cycle checkpoints) LNCaP (prostate cancer cell line)  LNCaP (prostate" exact="cancer" post="cell line )  ND ND [ 70 ] [ 71"/>
   <result pre="] [ 71 ] Active (induction of apoptosis) p53-null myeloblastic" exact="leukemia" post="HL 60 cells 23  µM  [ 72 ] Active"/>
   <result pre="independent (C4-2B) 100  μmol/L [ 73 ] AR naive (PC-3)" exact="prostate cancer" post="cells 86  μmol/L Active (cell cycle arrest; induction of"/>
   <result pre="(C4-2B) 100  μmol/L [ 73 ] AR naive (PC-3) prostate" exact="cancer" post="cells 86  μmol/L Active (cell cycle arrest; induction of"/>
   <result pre="77 ] Active (inhibition of PDE1A expression) Jurkat cell (acute" exact="lymphoblastic leukemia" post="cell line) ND [ 79 ] Active (downregulated MUC4"/>
   <result pre="] Active (inhibition of PDE1A expression) Jurkat cell (acute lymphoblastic" exact="leukemia" post="cell line) ND [ 79 ] Active (downregulated MUC4"/>
   <result pre="Active (downregulated MUC4 expression and induction of apoptosis) The MUC4-expressing" exact="pancreatic cancer" post="cells FG/COLO357 CD18/HPAF 73  μmol/L 73  μmol/L [ 80"/>
   <result pre="(downregulated MUC4 expression and induction of apoptosis) The MUC4-expressing pancreatic" exact="cancer" post="cells FG/COLO357 CD18/HPAF 73  μmol/L 73  μmol/L [ 80"/>
   <result pre="(upregulation of PTEN expression and induction of apoptosis) Doxorubicin-resistant human" exact="breast cancer" post="MCF-7/DOX cell 35–70% a [ 82 ] Active (ND)"/>
   <result pre="of PTEN expression and induction of apoptosis) Doxorubicin-resistant human breast" exact="cancer" post="MCF-7/DOX cell 35–70% a [ 82 ] Active (ND)"/>
   <result pre="[ 81 ] Active (thymoquinone-loaded nanoparticles activity) MDA-MB-231 (human metastatic" exact="breast cancer" post="cell line) ND [ 84 ] Active (comparison of"/>
   <result pre="81 ] Active (thymoquinone-loaded nanoparticles activity) MDA-MB-231 (human metastatic breast" exact="cancer" post="cell line) ND [ 84 ] Active (comparison of"/>
   <result pre="Active (comparison of thymoquinone versus thymoquinone-loaded nanoparticles activities) HCT-116 (colon" exact="cancer" post="cell line) 15% versus 85% b   [ 83 ]"/>
   <result pre="line) 15% versus 85% b   [ 83 ] MCF-7 (breast" exact="cancer" post="cell line) 30% versus 88% b  PC-3 (prostate cancer"/>
   <result pre="(breast cancer cell line) 30% versus 88% b  PC-3 (prostate" exact="cancer" post="cell line) 30% versus 85% b  U-266 (multiple myeloma"/>
   <result pre="myeloma cell line) 55% versus 70% b   HCT116 (colon" exact="cancer" post="cell line) 24% c    Activity of derivatives of"/>
   <result pre="line) 24% c    Activity of derivatives of thymoquinone HCT116p53−/−" exact="colon cancer" post="72% c  [ 85 ]   HepG2 (hepatocellular carcinomic"/>
   <result pre="24% c    Activity of derivatives of thymoquinone HCT116p53−/− colon" exact="cancer" post="72% c  [ 85 ]   HepG2 (hepatocellular carcinomic"/>
   <result pre="human cell line)  75% c     HL-60 (acute promyelocytic" exact="leukemia" post="cells) 0.13–&amp;gt;100  µM∗    Activity of analogs of thymoquinone"/>
   <result pre="phosphorylation; induction of apoptosis; inhibition of HDAC2 proteins) LNM35 (human" exact="lung cancer" post="cell) 50–78  µM∗    HepG2 (human hepatoma cell) 34 "/>
   <result pre="induction of apoptosis; inhibition of HDAC2 proteins) LNM35 (human lung" exact="cancer" post="cell) 50–78  µM∗    HepG2 (human hepatoma cell) 34 "/>
   <result pre="  HepG2 (human hepatoma cell) 34  µM    HT29 (human" exact="colorectal cancer" post="cell) 50–78  µM∗  [ 96 ] MDA-MB-435 (human mammary"/>
   <result pre="HepG2 (human hepatoma cell) 34  µM    HT29 (human colorectal" exact="cancer" post="cell) 50–78  µM∗  [ 96 ] MDA-MB-435 (human mammary"/>
   <result pre="carcinoma)  18.06  µM Active (induction of apoptosis) HL-60 (human promyelocytic" exact="leukemia" post="cell)  27.8  µM [ 93 ] 518A2 (melanoma cell"/>
   <result pre="µM   Multidrug-resistant variants 18.7–57.2  µM∗     MCF-7 (breast" exact="cancer" post="cell line) 32–48  µM∗    Active (modulation of the"/>
   <result pre="Active (modulation of the PPAR- γ activation pathway) MDA-MB-231 (breast" exact="cancer" post="cell line) 11–24  µM∗  [ 193 ]   BT-474"/>
   <result pre="cell line) 11–24  µM∗  [ 193 ]   BT-474 (breast" exact="cancer" post="cell line)  18–38  µM∗   Active (condition T cells"/>
   <result pre="T cells in vitro for adoptive T cell therapy against" exact="cancer" post="and infectious disease) OT-1 (transgenic CD8+) T cells ND"/>
   <result pre="[ 95 ] Active (induction of apoptosis) Mouse model of" exact="familial adenomatous polyposis" post="375 mg/kg [ 97 ] Active (comparison of thymoquinone and"/>
   <result pre="(comparison of thymoquinone and thymoquinone in liposomes effects) MCF-7 (breast" exact="cancer" post="cell line) T47D (breast cancer cell line) 40  µM"/>
   <result pre="in liposomes effects) MCF-7 (breast cancer cell line) T47D (breast" exact="cancer" post="cell line) 40  µM versus 200  µM 15  µM"/>
   <result pre="  Active (antimicrotubule drug)          U87 (human" exact="astrocytoma" post="cell line-solid tumor model)           ND"/>
   <result pre="      ND [ 101 ] Jurkat cells (acute" exact="lymphoblastic leukemia" post="cell line)       ND      "/>
   <result pre="    ND [ 101 ] Jurkat cells (acute lymphoblastic" exact="leukemia" post="cell line)       ND      "/>
   <result pre="      ND       Active Mouse P388" exact="leukemia" post="cell ND [ 17 ]   HeLa (human cervical"/>
   <result pre="arrest and induction of apoptosis) B16F10 (murine melanoma) K562 (erythromyeloblastoid" exact="leukemia" post="cell line) 12.27  µg/mL ND  [ 9 ] Active"/>
   <result pre="diet [ 121 ] Active (induction of apoptosis) K562 (erythromyeloblastoid" exact="leukemia" post="cell line) HL-60 (acute promyelocytic leukemia cells) ND ND"/>
   <result pre="of apoptosis) K562 (erythromyeloblastoid leukemia cell line) HL-60 (acute promyelocytic" exact="leukemia" post="cells) ND ND [ 110 ] Active (ND) Colonic"/>
   <result pre="(human breast adenocarcinoma) 14  µg/mL   Active (ND) K562 (erythromyeloblastoid" exact="leukemia" post="cell line)  16  µg/mL  [ 106 ]   PC12"/>
   <result pre="147 ] Active (cell cycle arrest; induction of apoptosis) Bcr/Abl-transformed" exact="leukemia" post="cells ND [ 148 ] Active (cell cycle arrest"/>
   <result pre="line)  550  µmol/L   Active (induction of apoptosis) K562 (erythromyeloblastoid" exact="leukemia" post="cell line) 81.0  µmol/L [ 133 ] Active (antiangiogenic"/>
   <result pre="ND [ 135 , 136 ] Active (c-Myc-dependent apoptosis) Bcr/Abl-transformed" exact="leukemia" post="cells ND [ 134 ] Active (cell cycle arrest;"/>
   <result pre="Active (modulation of the expression of AP-1 target genes) Breast" exact="cancer" post="cells ND [ 140 ] Active (antitumor effect potentiated"/>
   <result pre="800–2400 mg/m 2/dose [ 153 ]  Active (telomerase activity)    Prostate" exact="cancer" post="cells    ND    [ 132 ]   Active"/>
   <result pre="carcinomic human cell line); HeLa (human cervical carcinoma); MOLT-4 (human" exact="lymphoblastic leukemia" post="T cell line); K-562 (human chronic myelogenous leukemia cell"/>
   <result pre="human cell line); HeLa (human cervical carcinoma); MOLT-4 (human lymphoblastic" exact="leukemia" post="T cell line); K-562 (human chronic myelogenous leukemia cell"/>
   <result pre="(human lymphoblastic leukemia T cell line); K-562 (human chronic myelogenous" exact="leukemia" post="cell line); CTVR-1 (an early B cell line from"/>
   <result pre="     ND   Active (ND) K-562 (human chronic myelogenous" exact="leukemia" post="cell line)  ND  [ 106 ]   PC-12 (rat"/>
   <result pre="(epithelioid carcinomic cell line)  ND   Active (ND) MOLT-4 (human" exact="lymphoblastic leukemia" post="T-cell line)  ND [ 14 ]   K-562 (human"/>
   <result pre="carcinomic cell line)  ND   Active (ND) MOLT-4 (human lymphoblastic" exact="leukemia" post="T-cell line)  ND [ 14 ]   K-562 (human"/>
   <result pre="line)  ND [ 14 ]   K-562 (human chronic myelogenous" exact="leukemia" post="cell line) ND     CTVR-1 (early B cell"/>
   <result pre="(cell cycle arrest and induction of necrosis) AE17 (mesothelioma murine" exact="cancer" post="cells) B16 (melanoma cells) 0.01–0.02 0.04–0.05 [ 163 ]"/>
   <result pre="      Active (ND)       P388 mouse" exact="leukemia" post="cells       ND       ["/>
   <result pre="c [ 165 ] Active (induction of apoptosis-activating p53) Endometrial" exact="cancer" post="cell lines Ishikawa and ECC-1 (endometrial carcinoma cell line)"/>
   <result pre="Active (induction of apoptosis)        NB4 (acute promyelocytic" exact="leukemia" post="cell line)         3.995  µg/mL   "/>
   <result pre="(induction of oxidative stress) Cultured primary rat neuron and N2a" exact="neuroblastoma" post="(NB) cells ND [ 169 ] Active (ND) MCF-7"/>
   <result pre="carcinoma) 0.63  μM [ 46 ] K-562 (human chronic myelogenous" exact="leukemia" post="cell line)  0.17  μM P-815 (mouse lymphoblast like mastocytoma"/>
   <result pre="myelogenous leukemia cell line)  0.17  μM P-815 (mouse lymphoblast like" exact="mastocytoma" post="cell line)  0.16  μM CEM (human acute lymphoblastic leukemia)"/>
   <result pre="human cell) 1393.3  µg/mL     K562 (human chronic myelogenous" exact="leukemia" post="cell line)  679.1  µg/mL   Active (ND) H-460 (lung"/>
   <result pre="5 [ 171 ] Active (induction of apoptosis) U937 (histiocytic" exact="lymphoma" post="cells) ND [ 172 ]   HeLa (human cervical"/>
   <result pre="ND [ 109 ] Active (cell cycle arrest) (Caco-2) human" exact="colon cancer" post="cell line 70% a [ 179 ] Active (blockade"/>
   <result pre="[ 109 ] Active (cell cycle arrest) (Caco-2) human colon" exact="cancer" post="cell line 70% a [ 179 ] Active (blockade"/>
   <result pre="the morphological and functional differentiation of the cells) Human colonic" exact="cancer" post="cells 30% c [ 175 ]   Caco-2 (human"/>
   <result pre="cells) 21.7  µg/mL [ 184 ] Active (ND) U937 (histiocytic" exact="lymphoma" post="cell line) P3HR1 (Burkitt lymphoma cell line) 3.51  µg/mL"/>
   <result pre="] Active (ND) U937 (histiocytic lymphoma cell line) P3HR1 (Burkitt" exact="lymphoma" post="cell line) 3.51  µg/mL  4.21  µg/mL  [ 185 ]"/>
   <result pre="Active (induction of apoptosis; promotion cell differentiation) HL-60 (acute promyelocytic" exact="leukemia" post="cells) ND [ 190 ] Active (combination of doxorubicin-linalool"/>
   <result pre="µg/mL  46.0  µg/mL [ 50 ] Active (ND) MCF-7 (human" exact="breast cancer" post="cells) 1.3 mg/L [ 192 ] ND: not determined. ∗Variable"/>
   <result pre=" 46.0  µg/mL [ 50 ] Active (ND) MCF-7 (human breast" exact="cancer" post="cells) 1.3 mg/L [ 192 ] ND: not determined. ∗Variable"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4224956/results/search/disease/results.xml">
   <result pre="[18844256] Monsefi M Alaee S Moradshahi A Rohani L Cadmium‐induced" exact="infertility" post="in male mice Environ Toxicol 2010 25 94 102"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4242925/results/search/disease/results.xml">
   <result pre="Chinese medicine, the drug is used to treat impotence and" exact="hernia" post="( 3 ). It has been used in Indian"/>
   <result pre="an antipyretic, diuretic, and supportive, and for treatment of dropsy," exact="heart disease," post="chronic cough, and enlargement of the spleen and the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4311404/results/search/disease/results.xml">
   <result pre="followed by oral azithromycin monotherapy in hospitalized patients with community-acquired" exact="pneumonia" post="Antimicrob Agents Ch 44 1796 1802 2000 4 O'doherty"/>
   <result pre="in the treatment of adults with mild to moderate community-acquired" exact="pneumonia" post="Eur J Clin Microbiol 17 828 833 1998 5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4311427/results/search/disease/results.xml">
   <result pre="49 ]. And the behavior response is affected by the" exact="suppression" post="of DmelOBP99b for both females and males. And benzaldehyde"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4319901/results/search/disease/results.xml">
   <result pre="]. For male rats, the incidence of exacerbated chronic progressive" exact="nephropathy" post="in dose finding studies was used to predict renal"/>
   <result pre=", Betz LJ , Kissling GE ( 2011) Chronic progressive" exact="nephropathy" post="in male F344 rats in 90-day toxicity studies: Its"/>
   <result pre="data-based assessment of alternative strategies for identification of potential human" exact="cancer" post="hazards . Toxicologic Pathology 37: 714– 732. doi: 10.1177/0192623309343779"/>
   <result pre="1996) A critical appraisal of the value of the mouse" exact="cancer" post="bioassay in safety assessment. Toxicologic Pathology 24: 722– 725."/>
   <result pre="( 2005) Cancer in rodents: Does it tell us about" exact="cancer" post="in humans? Nature Reviews Cancer 5: 807– 819. [16195752]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4322175/results/search/disease/results.xml">
   <result pre="this study, oocyte changes as one of probable reasons of" exact="infertility" post="were investigated. Methods In this study, 59 adult female"/>
   <result pre="(p &amp;lt; 0.05). Conclusion Dill seed aqueous extract can induce" exact="infertility" post="without any effect on oocyte structure. Introduction Anethum graveolens"/>
   <result pre="), antioxidant ( 2 ), antihypercholesterolemic ( 3 ), and" exact="cancer" post="chemo-preventive effects ( 4 ) have been reported. In"/>
   <result pre="rats revealed that only water fraction of aqueous extract caused" exact="infertility" post="( 12 ). Also, there is no other research"/>
   <result pre="dose increased estrous cycle duration and progesterone concentration and induced" exact="infertility" post="without any significant adverse effects on oocytes’ developmental potential"/>
   <result pre="GQ Kenney PM Lam LK Anethofuran, carvone, and limonene: potential" exact="cancer" post="chemopreventive agents from dill weed oil and caraway oil"/>
   <result pre="characteristics of rat ovaries and endometrium in experimental hyper- and" exact="hypothyroidism" post="Folia Histochem Cytobiol. 2012 50 3 331 9 [23042262]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4339706/results/search/disease/results.xml">
   <result pre="cavity, is a plaque-related disease of teeth and slowly progressive" exact="infectious disease" post="in the dental area [ 1 , 2 ]."/>
   <result pre="in the dental area [ 1 , 2 ]. The" exact="dental caries" post="disease is caused by specific types of acid-producing bacteria"/>
   <result pre="generally regarded as one of the primary pathogenic bacteria in" exact="dental caries" post="[ 4 ]. The S. mutans adhere to the"/>
   <result pre="S. mutans is one of the strategies for prevention of" exact="dental caries." post="Although several antiplaque agents have been used, the attempt"/>
   <result pre="is considered as a major bacterium for the formation of" exact="dental caries" post="[ 5 , 23 ]. Our results showed that"/>
   <result pre="S. mutans is one of the strategies for prevention of" exact="dental caries." post="In dental plaque formation, pH is one of the"/>
   <result pre="to demineralized tooth enamel and favors the occurrence of the" exact="dental caries." post="S. mutans can metabolize dietary sugars and produce organic"/>
   <result pre="result suggests that C. boreale essential oil may be inhibiting" exact="dental caries" post="through inhibition of acid production by S. mutans. Furthermore,"/>
   <result pre="appears to be a promising new agent that may prevent" exact="dental caries." post="Acknowledgment This research was supported by Basic Science Research"/>
   <result pre="role of LIM mineralization protein 1 in tertiary dentinogenesis of" exact="dental caries" post="treatment Medical Hypotheses 2007 69 3 584 586 [10.1016/j.mehy.2007.01.031]"/>
   <result pre="J. M. Oral microbiology: current concepts in the microbiology of" exact="dental caries" post="and periodontal disease British Dental Journal 1992 172 7"/>
   <result pre="microbiology: current concepts in the microbiology of dental caries and" exact="periodontal disease" post="British Dental Journal 1992 172 7 271 278 [10.1038/sj.bdj.4807849]"/>
   <result pre="Oh H.-J. 2′,4′,6′-tris(methoxymethoxy) chalcone (TMMC) attenuates the severity of cerulein-induced" exact="acute pancreatitis" post="and associated lung injury American Journal of Physiology: Gastrointestinal"/>
   <result pre="H.-J. 2′,4′,6′-tris(methoxymethoxy) chalcone (TMMC) attenuates the severity of cerulein-induced acute" exact="pancreatitis" post="and associated lung injury American Journal of Physiology: Gastrointestinal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4344607/results/search/disease/results.xml">
   <result pre="them with a relevant pharmacological activity, such as cytotoxicity against" exact="cancer" post="cell lines [ 88 ]. The genes coding farnesyl-diphosphate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4346696/results/search/disease/results.xml">
   <result pre="flavescens were higher than those of the infected control. Bloody" exact="diarrhea" post="in the S. flavescens and Sinomenium acutum-treated groups was"/>
   <result pre="control group. In summary, the data of survival rates, bloody" exact="diarrhea" post="symptoms, lesion scores, body weight gains, and oocyst excretions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4359887/results/search/disease/results.xml">
   <result pre="amastigote forms of L. tropica (MRHO/IR/75/ER) and then tested on" exact="cutaneous leishmaniasis" post="(CL) in male BALB/c mice with L. major to"/>
   <result pre="forms of L. tropica (MRHO/IR/75/ER) and then tested on cutaneous" exact="leishmaniasis" post="(CL) in male BALB/c mice with L. major to"/>
   <result pre="for the prevention and treatment of CL. 1. Introduction Cutaneous" exact="leishmaniasis" post="(CL) is caused by the transmission of Leishmania spp."/>
   <result pre="3 ]. At present, the current medications used to treat" exact="leishmaniasis" post="such as meglumine antimoniate and sodium stibogluconate are a"/>
   <result pre="various disease conditions such as stomach discomfort, nausea, vomiting, and" exact="motion sickness" post="[ 10 ]. In addition, reviews have reported P."/>
   <result pre="P. khinjuk extract at the concentration of 30% had potent" exact="suppression" post="effects on CL in male BALB/c mice infected with"/>
   <result pre="P. khinjuk extract at the concentration of 20% displayed the" exact="suppression" post="effects as intermediate. In line with our results, it"/>
   <result pre="it has been proven that gum obtained P. atlantica controlled" exact="cutaneous leishmaniasis" post="in mice infected with L. major [ 24 ]."/>
   <result pre="has been proven that gum obtained P. atlantica controlled cutaneous" exact="leishmaniasis" post="in mice infected with L. major [ 24 ]."/>
   <result pre="khinjuk alcoholic extract had potent antileishmanial activity and could control" exact="cutaneous leishmaniasis" post="in mice infected with L. major. This result also"/>
   <result pre="alcoholic extract had potent antileishmanial activity and could control cutaneous" exact="leishmaniasis" post="in mice infected with L. major. This result also"/>
   <result pre="in the traditional medicine for the prevention and treatment of" exact="cutaneous leishmaniasis." post="Acknowledgments This study was supported by the Razi Herbal"/>
   <result pre="5 Berman J. Clinical status of agents being developed for" exact="leishmaniasis" post="Expert Opinion on Investigational Drugs 2005 14 11 1337"/>
   <result pre="mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of" exact="cutaneous leishmaniasis" post="Experimental Parasitology 2007 116 3 233 240 [10.1016/j.exppara.2007.01.002] [2-s2.0-34248223638]"/>
   <result pre="infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous" exact="leishmaniasis" post="Experimental Parasitology 2007 116 3 233 240 [10.1016/j.exppara.2007.01.002] [2-s2.0-34248223638]"/>
   <result pre="efficacy of gum obtained Pistacia atlantica in experimental treatment of" exact="cutaneous leishmaniasis" post="Iranian Journal of Public Health 2010 39 1 36"/>
   <result pre="of gum obtained Pistacia atlantica in experimental treatment of cutaneous" exact="leishmaniasis" post="Iranian Journal of Public Health 2010 39 1 36"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4371224/results/search/disease/results.xml">
   <result pre="In addition, the extensive search for new drugs to treat" exact="leishmaniasis" post="is definitely necessary because the limited number of currently"/>
   <result pre="clinical spectrum of manifestations that includes all three forms of" exact="leishmaniasis" post="(cutaneous, mucosal and visceral) ( Rocha et al. 2005"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4372811/results/search/disease/results.xml">
   <result pre="in turn reconcile potentiation of odor-induced OSN activity and the" exact="suppression" post="of forskolin-induced activity in some OSNs. Given that M3-Rs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4387231/results/search/disease/results.xml">
   <result pre="It has also been used in the treatment of fever," exact="common cold," post="rheumatic diseases, asthma, headache, warts, and stings of scorpions"/>
   <result pre="liver damages mediated by oxidative stress are including: a) alcoholic" exact="liver disease," post="b) fibrosis/cirrhosis, c) hepatic stellate cells, d) hepatocellular carcinoma,"/>
   <result pre="alcoholic liver disease, b) fibrosis/cirrhosis, c) hepatic stellate cells, d)" exact="hepatocellular carcinoma," post="e) ischemic/reperfusion liver injury, f) paracetamol-induced liver damage, g)"/>
   <result pre="carcinoma, e) ischemic/reperfusion liver injury, f) paracetamol-induced liver damage, g)" exact="viral hepatitis," post="h) fatty liver and i) chemical pollutant-induced liver damage"/>
   <result pre="i) chemical pollutant-induced liver damage ( 30 ). a) Alcoholic" exact="liver disease" post="Ethanol is a potent inducer of ROS production in"/>
   <result pre="ROS and lipid peroxidation is associated with liver fibrosis and" exact="cirrhosis" post="( 33 ). This effect can lead to the"/>
   <result pre="that oxidative stress has a critical role in fibrosis and" exact="cirrhosis" post="of liver ( 34 ). Free radicals initiate cell"/>
   <result pre="Oxidative stress and chronic inflammation are the common mechanisms for" exact="hepatocellular carcinoma" post="( 39 ). ROS interacts directly with DNA and"/>
   <result pre="( 40 ). ROS can directly stimulate the growth of" exact="cancer" post="cells. Chronic inflammation can worsen this state. The formation"/>
   <result pre="is a main evidence that ROS is a cause of" exact="hepatocellular carcinoma" post="( 41 ). e) Ischemic/reperfusion (I/R) liver injury Periods"/>
   <result pre="from toxicity of paracetamol overdoses ( 46 ). g) Viral" exact="hepatitis" post="Hepatitis C virus (HCV) and oxidative stress are parallel"/>
   <result pre="to cirrhosis. Up to 10% of cirrhotic fatty liver develop" exact="hepatocellular carcinoma." post="Free fatty acids are the main sources of production"/>
   <result pre="leading to oxidative stress is responsive for induced HCV-related fibrosis," exact="cirrhosis" post="and liver failure. Abdel-Moneim and co-workers showed that N."/>
   <result pre="function ( 47 ). The most common childhood malignancy is" exact="acute lymphoblastic leukemia," post="and the choice drug for treatment in children is"/>
   <result pre="( 47 ). The most common childhood malignancy is acute" exact="lymphoblastic leukemia," post="and the choice drug for treatment in children is"/>
   <result pre="effect of Nigella sativa oil on the formation of stress" exact="gastritis" post="in hypothyroidal rats Int J Physiol Pathophysiol Pharmacol 2009"/>
   <result pre="of Nigella sativa seed alcoholic and aqueous extracts on MCF-7" exact="breast cancer" post="cells alone or in combination with doxorubicin Cell Biochem"/>
   <result pre="Nigella sativa seed alcoholic and aqueous extracts on MCF-7 breast" exact="cancer" post="cells alone or in combination with doxorubicin Cell Biochem"/>
   <result pre="SZ Ying XZ Antitumor and anti-angiogenesis effects of thymoquinone on" exact="osteosarcoma" post="through the NF-κB pathway Oncol Rep 2013 29 571"/>
   <result pre="and inflammatory cytokine response by thymoquinone in the collagen induced" exact="arthritis" post="in Wistar rats Chem Biol Interact 2012 197 40"/>
   <result pre="X Dong W Thymoquinone Prevents and ameliorates dextran sulfate sodium-induced" exact="colitis" post="in mice Dig Dis Sci 2012 57 2296 2303"/>
   <result pre="dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and" exact="cirrhosis" post="Hepatology 1992 16 1014 1021 [1398481] 35 Wu J"/>
   <result pre="and N-hexane extract of Nigella sativa in paracetamol (acetaminophen) induced" exact="liver disease" post="of rats: a histopathological evaluation J Pharm 2013 4"/>
   <result pre="48 Seronello S Sheikh MY Choi J Redox regulation of" exact="hepatitis" post="C in nonalcoholic and alcoholic liver Free Radic Biol"/>
   <result pre="O Israeli E Ackerman Z Pappo O Treatment of chronic" exact="hepatitis" post="C virus infection via antioxidants: results of a phase"/>
   <result pre="sativa seeds extract and thymoquinone on mouse cells infected with" exact="schistosomiasis" post="using karyotyping Mutat Res 2002 516 11 17 [11943605]"/>
   <result pre="57 Al Rowais NA Herbal medicine in the treatment of" exact="diabetes mellitus" post="Saudi Med J 2002 23 1327 1331 [12506289] 58"/>
   <result pre="NF-kappaB in the bain and spinal cord of experimental autoimmune" exact="encephalomyelitis" post="Biomed Sci Instrum 2005 41 388 393 [15850137] 62"/>
   <result pre="431 436 [15648658] 72 Mahgoub AA Thymoquinone protects against experimental" exact="colitis" post="in rats Toxicol Lett 2003 143 133 143 [12749817]"/>
   <result pre="A Effects of thymoquinone (volatile oil of black cumin) on" exact="rheumatoid arthritis" post="in rat models Phytother Res 2007 21 895 897"/>
   <result pre="Effects of thymoquinone (volatile oil of black cumin) on rheumatoid" exact="arthritis" post="in rat models Phytother Res 2007 21 895 897"/>
   <result pre="MH Hamada FM The influence of thymoquinone on doxorubicine-induced hyperlipidemic" exact="nephropathy" post="in rats Toxicology 2000 143 219 226 [10755708] 76"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4389268/results/search/disease/results.xml">
   <result pre="[10.1016/0028-3908(80)90187-2] [6104308] Baraban JM Wang RY Aghajanian G 1978 Reserpine" exact="suppression" post="of dorsal raphe neuronal firing: mediation by adrenergic system"/>
   <result pre="J Lucki I Drevets WC 2009 5-HT(1A) receptor function in" exact="major depressive disorder" post="Progress in Neurobiology 88 17 31 [10.1016/j.pneurobio.2009.01.009] [19428959] Schmitzer-Torbert"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4408633/results/search/disease/results.xml">
   <result pre="L. (Diptera: Culicidae) is the major vector of dengue and" exact="chikungunya" post="fever. The lack of effective therapies and vaccines for"/>
   <result pre="9 ]. Some acute virus diseases, such as dengue and" exact="chikungunya" post="fever, are transmitted through the bite of female Aedes"/>
   <result pre="new products to combat the spread of the dengue and" exact="chikungunya" post="virus. The main aim of this study was to"/>
   <result pre="Aedes aegypti L. is an important vector of dengue and" exact="chikungunya" post="fever, diseases that still cause high morbidity and mortality"/>
   <result pre="promising tool to help reduce the spread of dengue and" exact="chikungunya" post="fever. This is because these products are the natural"/>
   <result pre="Switzerland] [World Health Organization] 13 Morrison T. E. Reemergence of" exact="chikungunya" post="virus Journal of Virology 2014 88 20 11644 11647"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4413252/results/search/disease/results.xml">
   <result pre="only to better understand the mechanism by which multidrug-resistant (MDR)" exact="cancer" post="cells occur, but also to boost the discovery of"/>
   <result pre="flora in the discovery of potential cytotoxic phytochemicals against MDR" exact="cancer" post="cells. Methodology. Scientific databases such as PubMed, ScienceDirect, Scopus,"/>
   <result pre="publications related to African plants, isolated compounds, and drug resistant" exact="cancer" post="cells. The data were analyzed to highlight cytotoxicity and"/>
   <result pre="Africa [ 1 , 2 ]. The number of new" exact="cancer" post="cases will reach 15 million every year by 2020"/>
   <result pre="countries, where governments are less prepared to address the growing" exact="cancer" post="burden and where survival rates are often less than"/>
   <result pre="[ 1 ]. Currently, limited funding is available to tackle" exact="cancer" post="in African countries. Awareness of this impeding epidemic in"/>
   <result pre="transporters contributes to MDR and participates in the failure of" exact="cancer" post="chemotherapy [ 7 ]. MDR cancer cells reveal cross-resistance"/>
   <result pre="in the failure of cancer chemotherapy [ 7 ]. MDR" exact="cancer" post="cells reveal cross-resistance to a variety of chemically and"/>
   <result pre="for Research on Cancer (IARC) revealed that about 715,000 new" exact="cancer" post="cases and 542,000 cancer deaths occurred in 2008 in"/>
   <result pre="(IARC) revealed that about 715,000 new cancer cases and 542,000" exact="cancer" post="deaths occurred in 2008 in Africa [ 12 ]."/>
   <result pre="[ 12 ]. There will be about 1.28 million new" exact="cancer" post="cases and 970,000 cancer deaths by 2030 solely in"/>
   <result pre="will be about 1.28 million new cancer cases and 970,000" exact="cancer" post="deaths by 2030 solely in Africa, mainly due to"/>
   <result pre="diet, and physical inactivity [ 13 ]. The most occurring" exact="cancer" post="types in Africa are those related to infectious agents"/>
   <result pre="as well as Kaposi sarcoma) [ 1 ]. In 2008," exact="cervical cancer" post="accounted for 21% of the total newly diagnosed cancers"/>
   <result pre="well as Kaposi sarcoma) [ 1 ]. In 2008, cervical" exact="cancer" post="accounted for 21% of the total newly diagnosed cancers"/>
   <result pre="21% of the total newly diagnosed cancers in females and" exact="liver cancer" post="for 11% of the total cancer cases in males"/>
   <result pre="of the total newly diagnosed cancers in females and liver" exact="cancer" post="for 11% of the total cancer cases in males"/>
   <result pre="in females and liver cancer for 11% of the total" exact="cancer" post="cases in males [ 1 ]. The survival rates"/>
   <result pre="lower in Africa than in the developed world for most" exact="cancer" post="types [ 1 ]. For example, the five-year survival"/>
   <result pre="[ 1 ]. For example, the five-year survival rate for" exact="breast cancer" post="is less than 50% in Gambia, Uganda, and Algeria,"/>
   <result pre="1 ]. For example, the five-year survival rate for breast" exact="cancer" post="is less than 50% in Gambia, Uganda, and Algeria,"/>
   <result pre="World Health Organization (WHO) government survey of national capacity for" exact="cancer" post="control programs in 2001, anticancer drugs were only available"/>
   <result pre="Africa were found to be active against various types of" exact="cancer" post="cells. Even if not reported in the scientific literature"/>
   <result pre="presence of adenosine triphosphate-binding cassette (ABC) transporters, such as the" exact="breast cancer" post="resistance protein (BCRP/ABCG2) and P-glycoprotein (P-gp/MDR1/ABCB1) [ 4 ]"/>
   <result pre="of adenosine triphosphate-binding cassette (ABC) transporters, such as the breast" exact="cancer" post="resistance protein (BCRP/ABCG2) and P-glycoprotein (P-gp/MDR1/ABCB1) [ 4 ]"/>
   <result pre="defense mechanism against harmful substances during evolution of life. Some" exact="cancer" post="cells overexpress P-gp rendering these cancers multidrug resistant ["/>
   <result pre="to EGFR overexpression have been associated with many cancers, including" exact="lung cancer," post="anal cancers, and glioblastoma multiforme [ 25 , 26"/>
   <result pre="associated with many cancers, including lung cancer, anal cancers, and" exact="glioblastoma multiforme" post="[ 25 , 26 ]. Human tumor suppressor protein"/>
   <result pre="cell cycle and, therefore, functions as a tumor suppressor, preventing" exact="cancer" post="[ 27 ]. Consequently p53 has been described as"/>
   <result pre="[ 30 ]. Topoisomerases have also become popular targets for" exact="cancer" post="chemotherapy treatments, as their inhibitors block the ligation step"/>
   <result pre="and 10-fold higher than 20  μg/mL as corresponding values in" exact="cancer" post="cells. In this report, we propose the following cutoff"/>
   <result pre="Egypt, Nigeria, and Madagascar. The majority of reports on MDR" exact="cancer" post="cell lines were from Cameroonian plants and derived molecules."/>
   <result pre="screened for their antiproliferative activities on both sensitive and resistant" exact="cancer" post="cell lines ( Table 1 ). The cytotoxicity of"/>
   <result pre="active at various degrees towards drug-resistant as well as sensitive" exact="cancer" post="cells [ 37 ]. Aframomum polyanthum and mostly A."/>
   <result pre="and mostly A. arundinaceum demonstrated the best activities towards multidrug-resistant" exact="leukemia" post="CEM/ADR5000 cells (degree of resistance (D.R.) or ratio of"/>
   <result pre="adenocarcinoma MDA-MB-231/ BCRP cells (D.R.: 0.89 and 1.02, resp.), and" exact="glioblastoma multiforme" post="U87MG.Δ EGFR cells (D.R.: &amp;lt;0.51 and 0.95, resp.) compared"/>
   <result pre="(Annonaceae) harvested in Cameroon were also reported on various drug-resistant" exact="cancer" post="cell lines ( Table 1 ), with collateral sensitivity"/>
   <result pre="a strong cytotoxicity towards a panel on sensitive and resistant" exact="cancer" post="cell lines as shown in Table 1 . Xylopia"/>
   <result pre="and Dorstenia psilurus Welw. (Moraceae) showed strong effects on both" exact="leukemia" post="CCRF-CEM and their drug-resistant subline CEM/ADR5000 cells (D.R.: 1.9,"/>
   <result pre="of Echinops giganteus [ 40 ]. Other Cameroonian spices with" exact="hypersensitivity" post="to CEM/ADR5000 compared to parental sensitive CCRF-CEM cells include"/>
   <result pre="a strong cytotoxicity on a panel of drug-resistant and -sensitive" exact="cancer" post="cell lines [ 41 ]. Interestingly, collateral sensitivity to"/>
   <result pre="Kosterm (Lauraceae) also showed good activities towards drug-sensitive and -resistant" exact="cancer" post="cell lines ( Table 1 ), with lower degree"/>
   <result pre="of resistance than doxorubicin [ 20 ]. In fact, the" exact="hypersensitivity" post="of colon carcinoma HCT116 ( p53 −/−) cells to"/>
   <result pre="their antiproliferative effects towards a panel of drug-sensitive and -resistant" exact="cancer" post="cell lines ( Table 1 ) [ 42 ]."/>
   <result pre="demonstrated a strong inhibitory effect on nine of nine tested" exact="cancer" post="cell lines with other plants showing selective activities. Amongst"/>
   <result pre="with other plants showing selective activities. Amongst these plants, the" exact="hypersensitivity" post="of the resistant MDA-MB-231/ BCRP cells (D.R. 0.62 compared"/>
   <result pre="for their cytotoxic potential against four cell lines, namely, human" exact="pancreatic cancer" post="MiaPaCa-2 cells, breast cancer MCF-7 cells, leukemia CCRF-CEM cells,"/>
   <result pre="their cytotoxic potential against four cell lines, namely, human pancreatic" exact="cancer" post="MiaPaCa-2 cells, breast cancer MCF-7 cells, leukemia CCRF-CEM cells,"/>
   <result pre="against four cell lines, namely, human pancreatic cancer MiaPaCa-2 cells," exact="breast cancer" post="MCF-7 cells, leukemia CCRF-CEM cells, and their multidrug-resistant subline"/>
   <result pre="four cell lines, namely, human pancreatic cancer MiaPaCa-2 cells, breast" exact="cancer" post="MCF-7 cells, leukemia CCRF-CEM cells, and their multidrug-resistant subline"/>
   <result pre="namely, human pancreatic cancer MiaPaCa-2 cells, breast cancer MCF-7 cells," exact="leukemia" post="CCRF-CEM cells, and their multidrug-resistant subline CEM/ADR5000 cells ["/>
   <result pre="Vitis vinifera (brown seeds) against CEM/ADR5000 cells did not inhibit" exact="cancer" post="cell growth [ 43 ]. All other extracts were"/>
   <result pre="isolated in African medicinal plants were screened rather on drug-sensitive" exact="cancer" post="cell lines. These include oleanane-type triterpenoid saponins; gummiferaosides A,"/>
   <result pre="of 0.8, 1.5, and 0.6  μg/mL, resp., on A2780 human" exact="ovarian cancer" post="cells) obtained from the roots of the Madagascan plant"/>
   <result pre="0.8, 1.5, and 0.6  μg/mL, resp., on A2780 human ovarian" exact="cancer" post="cells) obtained from the roots of the Madagascan plant"/>
   <result pre="of 1.4, 0.83, 1.0, and 1.0  μM, resp., against A2780" exact="cancer" post="cells) isolated from Casearia nigrescens (Flacourtiaceae) harvested in Madagascar"/>
   <result pre="(IC 50 of 0.12 and 0.07  μM, resp., against A2780" exact="cancer" post="cells; 0.15 and 0.08  μM against the U937 human"/>
   <result pre="cells; 0.15 and 0.08  μM against the U937 human histiocytic" exact="lymphoma" post="cell line, resp.) isolated from another Madagascan plant Elaeodendron"/>
   <result pre="medicinal plant Ferula hermonis exerted a strong cytotoxic effect towards" exact="breast cancer" post="cell line MCF7 and moderate activities towards other cell"/>
   <result pre="plant Ferula hermonis exerted a strong cytotoxic effect towards breast" exact="cancer" post="cell line MCF7 and moderate activities towards other cell"/>
   <result pre="43 ]. However, this compound was as active on resistant" exact="leukemia" post="CEM/ADR5000 cell line as towards its sensitive parental CCRF-CEM"/>
   <result pre="Cameroonian spice Aframomum arundinaceum demonstrated moderate, but selective, cytotoxicity towards" exact="cancer" post="cell lines [ 37 ] ( Table 1 )."/>
   <result pre="compounds 2 and 3 were generally less active towards resistant" exact="cancer" post="cells, with 3 showing collateral sensitivity towards resistant breast"/>
   <result pre="Uapaca togoensis collected in Cameroon, displayed strong cytotoxicity towards sensitive" exact="leukemia" post="CCRF-CEM cells, but cross-resistance was also noted towards CEM/ADR5000"/>
   <result pre="cells (D.R.: 5.09 for 1 and 7.11 for doxorubicin), and" exact="glioblastoma multiforme" post="U87MG.Δ EGFR cells (D.R.: 3.94 for 1 and 5.76"/>
   <result pre="reported for their effects towards sensitive as well as drug-resistant" exact="cancer" post="cell lines ( Figure 2). Some of the most"/>
   <result pre="isolated from Uapaca togoensis, displayed a strong activity, combined with" exact="hypersensitivity" post="against leukemia CEM/ADR5000 cells compared to CCRF-CEM cells ["/>
   <result pre="Uapaca togoensis, displayed a strong activity, combined with hypersensitivity against" exact="leukemia" post="CEM/ADR5000 cells compared to CCRF-CEM cells [ 41 ]."/>
   <result pre="( 15) inhibited the proliferation of a panel of 14" exact="cancer" post="cell lines, including human leukemia CCRF-CEM cells and CEM/ADR5000,"/>
   <result pre="of a panel of 14 cancer cell lines, including human" exact="leukemia" post="CCRF-CEM cells and CEM/ADR5000, leukemia T cells PF-382, and"/>
   <result pre="cancer cell lines, including human leukemia CCRF-CEM cells and CEM/ADR5000," exact="leukemia" post="T cells PF-382, and promyelocytic leukemia HL-60, pancreatic adenocarcinoma"/>
   <result pre="CCRF-CEM cells and CEM/ADR5000, leukemia T cells PF-382, and promyelocytic" exact="leukemia" post="HL-60, pancreatic adenocarcinoma MiaPaCa-2 and Capan-1, breast adenocarcinoma MCF-7,"/>
   <result pre="U87MG, lung adenocarcinoma A549, cervical carcinoma CaSki and HeLa, and" exact="skin melanoma" post="Colo-38 cells [ 52 ]. IC 50 values below"/>
   <result pre="38), and isoneorautenol ( 39) towards a panel multifactorial drug-resistant" exact="cancer" post="cells was documented too [ 54 ]. However, the"/>
   <result pre="in Cameroon, were also documented on several drug-sensitive and -resistant" exact="cancer" post="cells [ 55 ]. The reported effects were observed"/>
   <result pre="panel of sensitive and drug-resistant hematological, breast, colon, and glioblastoma" exact="cancer" post="cell lines [ 19 ]. The hypersensitivity of glioblastoma"/>
   <result pre="colon, and glioblastoma cancer cell lines [ 19 ]. The" exact="hypersensitivity" post="of glioblastoma U87MG.Δ EGFR cells compared to its parental"/>
   <result pre="Cameroonian plant, Polygonum limbatum Meisn. (Polygonaceae), to tackle MDR of" exact="cancer" post="cells was also reported. These flavonoids included three chalcones"/>
   <result pre="J. F. Gmel. (Combretaceae) was active on 11 of 12" exact="cancer" post="cell lines. IC 50 values below 10  μM were"/>
   <result pre="nonadecyl or excelsaperoxide ( 43) displayed significant activity against resistant" exact="leukemia" post="CEM/ADR5000 cells (IC 50: 1.07  μM) and CCRF-CEM cells"/>
   <result pre="African medicinal plants were reported for their cytotoxic effects on" exact="cancer" post="cells. However, data available from the screening of some"/>
   <result pre="3-hydroxy-1-methoxy-10-methyl-9-acridone, 1-hydroxy-3-methoxy-10-methyl-9-acridone, and 1-hydroxy-2,3-dimethoxy-10-methyl-9-acridone that showed moderate activity against human" exact="lung carcinoma" post="cells A549 (IC 50 values of 31 to 52 "/>
   <result pre="Figure 3) from Uapaca togoensis displayed strong activities in several" exact="cancer" post="cell lines, including MDR phenotypes ( Table 1 );"/>
   <result pre="cell lines, including MDR phenotypes ( Table 1 ); importantly," exact="hypersensitivity" post="to 44 was reported with CEM/ADR5000 cells (D.R.: 0.11"/>
   <result pre="showed antiproliferative effects on a panel of drug-sensitive and -resistant" exact="cancer" post="cell lines [ 62 ]. Nevertheless, the reported activities"/>
   <result pre="49), demonstrated a broad spectrum of cytotoxic activities including resistant" exact="cancer" post="cells [ 40 ], its inhibitory potential was found"/>
   <result pre="found to be moderate (IC 50 range: 19–38  μg/mL). However," exact="hypersensitivity" post="of HCT116 ( p53 −/−) (compared to HCT116 ("/>
   <result pre="Several African plant extracts and isolated compounds acting on MDR" exact="cancer" post="phenotypes were found to induce apoptosis and cell cycle"/>
   <result pre="were found to induce apoptosis and cell cycle arrest in" exact="cancer" post="cells. In this review, we proposed to classify the"/>
   <result pre="reported African medicinal plants with significant cytotoxic effects on MDR" exact="cancer" post="cells and showing very strong induction of apoptosis include"/>
   <result pre="phases. In fact, the cell cycle arrest in G0/G1 in" exact="leukemia" post="CCRF-CEM cells was reported with the extracts from Vepris"/>
   <result pre="and 21 demonstrated a very strong induction of apoptosis in" exact="leukemia" post="CCRF-CEM cells [ 19 ]; benzophenones 19 and 21"/>
   <result pre="In general, several crude extracts having inhibitory effect on MDR" exact="cancer" post="cells were reported not to induce the activation of"/>
   <result pre="the percentage of induction is below 5%. MMP disruption in" exact="cancer" post="cells was reported as one of the likely mechanisms"/>
   <result pre="of ROS production is below 3%. Increased ROS production in" exact="leukemia" post="CCRF-CEM cells was reported upon treatment with extracts from"/>
   <result pre="19– 21 were found not to increase ROS levels in" exact="leukemia" post="CCRF-CEM cells [ 19 ]. 7.5. Antiangiogenic Effects of"/>
   <result pre="in the cytotoxic effect of guieranone A ( 36) in" exact="leukemia" post="CCRF-CEM cells. Several pathways and biological functions were affected"/>
   <result pre="from ischemia and its expression is increased in consequence to" exact="hypoglycemia" post="[ 57 ], suggesting that 36 might cause hypoxic"/>
   <result pre="summary, transport mechanisms were deregulated as consequence of treatment of" exact="cancer" post="cells with 36 [ 57 ]. 8. Structure-Activity Relationship"/>
   <result pre="plants such as compounds 1– 6 were more toxic on" exact="leukemia" post="than on carcinoma cells [ 20 , 37 ,"/>
   <result pre="different degrees of activity on the majority of the studied" exact="cancer" post="cell lines [ 19 ]. An analysis of the"/>
   <result pre="methoxy (-OCH 3) substituents influences the activity of chalcones towards" exact="leukemia" post="as well as carcinoma cell lines. In fact, chalcone"/>
   <result pre="their ethnopharmacological relevance should be considered for cytotoxicity screenings in" exact="cancer" post="cells. The most cytotoxic plant extracts from African flora"/>
   <result pre="Fellowship for Experienced Researcher&quot; program. Abbreviations A2780 and SK-OV-3: Ovarian" exact="cancer" post="cells A549 and COR-L23: Lung carcinoma cells ABC: Adenosine"/>
   <result pre="COR-L23: Lung carcinoma cells ABC: Adenosine triphosphate-binding cassette BCRP: Breast" exact="cancer" post="resistance protein CCRF-CEM and the resistant subline CEM/ADR5000, HL60,"/>
   <result pre="+/+), and the resistant subline HCT116 ( p53 −/−): Colon" exact="cancer" post="cells DMAPP: Dimethylallyl diphosphate EGFR: Epidermal growth factor receptor"/>
   <result pre="MDA-MB-231/ BCRP: Breast adenocarcinoma cells MDR: Multidrug resistant MiaPaca-2: Prostate" exact="cancer" post="cells MMP: Mitochondrial membrane potential p53: Tumor suppressor p53"/>
   <result pre="[Oxford, UK] [Elsevier] 3 Vorobiof D. A. Abratt R. The" exact="cancer" post="burden in Africa South African Medical Journal 2007 97"/>
   <result pre="A. Booth-Genthe C. Gottesman M. M. Targeting multidrug resistance in" exact="cancer" post="Nature Reviews Drug Discovery 2006 5 3 219 234"/>
   <result pre="V. Efferth T. Pharmacogenomics of Cameroonian traditional herbal medicine for" exact="cancer" post="therapy Journal of Ethnopharmacology 2011 137 1 752 766"/>
   <result pre="W. S. Role of oncogenes in resistance and killing by" exact="cancer" post="therapeutic agents Current Opinion in Oncology 1997 9 1"/>
   <result pre="Berezov A. Wang Q. ErbB receptors: from oncogenes to targeted" exact="cancer" post="therapies The Journal of Clinical Investigation 2007 117 8"/>
   <result pre="alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant" exact="cancer" post="cell lines BMC Complementary and Alternative Medicine 2014 14"/>
   <result pre="compounds from the fruits of Uapaca togoensis towards multi-Factorial drug-resistant" exact="cancer" post="cells Planta Medica 2014 81 1 32 38 [10.1055/s-0034-1383362]"/>
   <result pre="other Cameroonian medicinal plants against drug sensitive and multidrug resistant" exact="cancer" post="cells BMC Complementary and Alternative Medicine 2013 13, article"/>
   <result pre="flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant" exact="cancer" post="cells Investigational New Drugs 2014 32 6 1053 1062"/>
   <result pre="senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi-factorial drug resistant" exact="cancer" post="cells Phytomedicine 2014 21 5 682 688 [10.1016/j.phymed.2013.10.017] [2-s2.0-84898056846]"/>
   <result pre="G, morusignin i and cudraxanthone I) against sensitive and multidrug-resistant" exact="cancer" post="cell lines Phytomedicine 2014 21 3 315 322 [2-s2.0-84896493532]"/>
   <result pre="action of 4′-hydroxy-2′,6′-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant" exact="cancer" post="cell lines Phytomedicine 2014 21 12 1651 1657 [10.1016/j.phymed.2014.08.001]"/>
   <result pre="Raj L. Ide T. Gurkar A. U. Selective killing of" exact="cancer" post="cells by a small molecule targeting the stress response"/>
   <result pre="isolated from African medicinal plants with documented effects on MDR" exact="cancer" post="cells. Alpha-hederin ( 1), galanal A ( 2), galanal"/>
   <result pre="isolated from African medicinal plants with documented activity on MDR" exact="cancer" post="cells. Naringenin ( 7), kaempferol-3,7,4′-trimethylether ( 8), candidone ("/>
   <result pre="49) isolated from African medicinal plants with relevance to MDR" exact="cancer" post="cells. Arborinin ( 44), buesgenine ( 45), isofagaridine ("/>
   <result pre="49). Table 1 African medicinal plants with demonstrated cytotoxicity on" exact="cancer" post="cell lines. Plant species (family) */area of plant collection"/>
   <result pre="[ 39 ] Aframomum polyanthum (Rutaceae), spices/Cameroon Bacterial infections and" exact="cancer" post="[ 37 ] Aframodial [ 73 ] Significant activities"/>
   <result pre="feet, spider bite, bronchitis, dysentery, sterility caused by poison, and" exact="gastroenteritis" post="[ 77 ]; syphilis, infectious diseases [ 78 ];"/>
   <result pre="]; syphilis, infectious diseases [ 78 ]; diarrhea, snake bite," exact="malaria" post="[ 79 ], and cancer [ 38 ] Alkaloids,"/>
   <result pre="78 ]; diarrhea, snake bite, malaria [ 79 ], and" exact="cancer" post="[ 38 ] Alkaloids, phenols, tannins, and triterpenes ["/>
   <result pre="[ 42 ] Dioscorea bulbifera L.(Dioscoreaceae)/Cameroon Sore throat and struma," exact="leprosy" post="and tumors, diabetes, and microbial infections [ 81 ,"/>
   <result pre="speciosa (Hochst.) Cufod. (Acanthaceae)/Cameroon Dysentery, anemia, irregular menstruation, hemorrhoids, and" exact="urinary tract infection" post="[ 96 ] Not reported Moderate activity of the"/>
   <result pre="43 ] Gladiolus quartinianus A. Rich (Iridaceae)/Cameroon Gastrointestinal infections and" exact="cancer" post="[ 38 ] Alkaloids, anthocyanins, phenols, saponins, tannins, and"/>
   <result pre="40 ] Olax subscorpioidea var. subscorpioidea Oliv. (Olacaceae), spice/Cameroon Constipation," exact="yellow fever," post="jaundice, venereal diseases, Guinea worm [ 101 ], and"/>
   <result pre="Malaria, fever, mental illness [ 111 ]; venereal infections and" exact="obesity" post="[ 112 , 113 ], and cancer [ 20"/>
   <result pre="venereal infections and obesity [ 112 , 113 ], and" exact="cancer" post="[ 20 ] Polysciasoside A, kalopanax-saponin B, and alpha-hederin"/>
   <result pre="µM) [ 20 ] Vepris soyauxii Engl. (Rutaceae)/Cameroon Antifibromyoma, stomachache," exact="malaria" post="[ 115 ], and cancer [ 38 ] Alkaloids,"/>
   <result pre="soyauxii Engl. (Rutaceae)/Cameroon Antifibromyoma, stomachache, malaria [ 115 ], and" exact="cancer" post="[ 38 ] Alkaloids, anthocyanins, phenols, saponins, tannins, and"/>
   <result pre="disorders [ 116 ], pneumonia, cough, fever, rheumatism, vomiting, and" exact="epilepsy" post="[ 117 ] and bacterial diseases [ 118 ]"/>
   <result pre="adenocarcinoma cells (MDA-MB231 and the resistant subline MDA-MB-231/ BCRP, MCF7)," exact="colon cancer" post="cells (DLD-1 and HCT15, HCT116 (p53 +/+ ), and"/>
   <result pre="cells (MDA-MB231 and the resistant subline MDA-MB-231/ BCRP, MCF7), colon" exact="cancer" post="cells (DLD-1 and HCT15, HCT116 (p53 +/+ ), and"/>
   <result pre="+/+ ), and the resistant subline HCT116 (p53 −/−)), and" exact="glioblastoma multiforme" post="(U87MG and the resistant subline U87MG.Δ EGFR)], hepatocarcinoma cells"/>
   <result pre="(U87MG and the resistant subline U87MG.Δ EGFR)], hepatocarcinoma cells (HepG2)," exact="lung carcinoma" post="cells (A549, COR-L23), leukemia cells (CCRF-CEM and the resistant"/>
   <result pre="U87MG.Δ EGFR)], hepatocarcinoma cells (HepG2), lung carcinoma cells (A549, COR-L23)," exact="leukemia" post="cells (CCRF-CEM and the resistant subline CEM/ADR5000, HL60, and"/>
   <result pre="CEM/ADR5000, HL60, and the resistant subline HL60AR), melanoma cells (SK-MEL-2)," exact="prostate cancer" post="cells (MiaPaca-2), and ovarian cancer cells (A2780 and SK-OV-3);"/>
   <result pre="HL60, and the resistant subline HL60AR), melanoma cells (SK-MEL-2), prostate" exact="cancer" post="cells (MiaPaca-2), and ovarian cancer cells (A2780 and SK-OV-3);"/>
   <result pre="subline HL60AR), melanoma cells (SK-MEL-2), prostate cancer cells (MiaPaca-2), and" exact="ovarian cancer" post="cells (A2780 and SK-OV-3); *the criteria of classification of"/>
   <result pre="HL60AR), melanoma cells (SK-MEL-2), prostate cancer cells (MiaPaca-2), and ovarian" exact="cancer" post="cells (A2780 and SK-OV-3); *the criteria of classification of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4415343/results/search/disease/results.xml">
   <result pre="medicine for vitiated vata, pain, Insomnia, abdominal disorders, cough, insanity," exact="erectile dysfunction," post="and inflammation. Acorus Calamus Linn. is a rhizomatous, perennial"/>
   <result pre="recommended in the NKB formulation due to its immunosuppressive activity," exact="diarrhea" post="and dysentery. Metabolic activity Hypoxia test NKB treated male"/>
   <result pre="85 ]. BR606 bone sorption inhibitor for the treatment of" exact="osteoporosis" post="and hypercalcemia [ 86 ] jatamansone (valeranone) hypotensive and"/>
   <result pre="vivo [ 104 ] mangiferin anti-necrosis in vivo, sedation and" exact="ptosis" post="in vivo, potentiation of amphetamine toxicity in vivo, potentiation"/>
   <result pre="]. Extract chondroprotective Effects [ 114 ] Fruits indigestion and" exact="constipation" post="[ 115 ]. Decoction of leaves fever fresh fruit"/>
   <result pre="3-Acetoxytropane, 3-Hydroxy-6-acetoxytropane, 3-Hydroxy-6-methylbutyryloxytropane, 3-Tigloloxy-6-isobutyryloxytropane, Aponorscopolamine, 7-Hydroxyhyoscyamine, Meteloidine, 3â, 6â-Ditigloyloxytropane. Extract" exact="asthma" post="treatment The ethanol extracts (leaf and seed) acaricidal, repellent"/>
   <result pre="malarial fever, dysentery, diarrhoea, skin diseases, hysteria, insomnia, gonorrhoea, colic," exact="tetanus" post="hydrophobia excessive use causes dyspepsia, cough, impotence, melancholy, dropsy,"/>
   <result pre="Decreases sebum/sebocytes proliferation, effective against methicillin-resistant staphylococcus aureus, pro-apoptotic against" exact="breast cancer" post="cell lines Cannabinol: Sedative, Antibiotic, Anti-convulsant, Anti-inflammatory, Decreases breast"/>
   <result pre="sebum/sebocytes proliferation, effective against methicillin-resistant staphylococcus aureus, pro-apoptotic against breast" exact="cancer" post="cell lines Cannabinol: Sedative, Antibiotic, Anti-convulsant, Anti-inflammatory, Decreases breast"/>
   <result pre="breast cancer cell lines Cannabinol: Sedative, Antibiotic, Anti-convulsant, Anti-inflammatory, Decreases" exact="breast cancer" post="resistant protein, effective against MRSA, Delta-9 tetrahydrocannabinol: Euphoriant, Analgesic,"/>
   <result pre="cancer cell lines Cannabinol: Sedative, Antibiotic, Anti-convulsant, Anti-inflammatory, Decreases breast" exact="cancer" post="resistant protein, effective against MRSA, Delta-9 tetrahydrocannabinol: Euphoriant, Analgesic,"/>
   <result pre="and methanolic extract antibacterial [ 139 , 141 ] extract" exact="asthma" post="[ 142 ]. The ethyl acetate fraction hypoglycemic, hypolipidemia"/>
   <result pre="[ 148 ] β-asarone and essential oil of the rhizomes:" exact="diarrhea" post="and dysentery [ 149 ] The essential oil and"/>
   <result pre="Linn. may be responsible for hypnotic activity but it showed" exact="diarrhea" post="and immunesuppressive activity (Table 3 ). Apart from this"/>
   <result pre="Muraoka A Yemato S Involvement of NO from nerves in" exact="diarrhea" post="induced by castor oil in rats Jpn J Pharmacol"/>
   <result pre="from N.jatamansi roots as bone sorption inhibitor for treatment of" exact="osteoporosis" post="and hypercalcemia. Jpn Kokai Tokkyo Koho. 1996;JP08041068. 87. Arora"/>
   <result pre="of Emblica officinalis Gaertn. Leaves extract in streptozotocin-induced type 2" exact="diabetes mellitus" post="(T2DM) rats J Ethnopharmacol 2012 142 65 71 [22855943]"/>
   <result pre="activity of Phyllanthus emblica fruits on prevention from indomethacin induced" exact="gastric ulcer" post="J Ethnopharmacol 2000 70 171 6 [10771207] 111. Thakur"/>
   <result pre="A Chondroprotective potential of fruit extracts of Phyllanthus emblica in" exact="osteoarthritis" post="Evid Based Complement Alternat Med 2008 5 329 35"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4424236/results/search/disease/results.xml">
   <result pre="to inhibit cell proliferation and, thus, reduce the spread of" exact="cancer" post="( 9 ). Essential oils are considered promising substances"/>
   <result pre="assuming equal variance. Cell lines and cell cultures The human" exact="hepatocellular carcinoma" post="HepG2 cell line was obtained from the American Type"/>
   <result pre="50 values (efficient concentration that causes a 50% decrease in" exact="cancer" post="cells viability) were calculated from the respective dose–response curves"/>
   <result pre="). Quite interestingly, in a study that used an ethylnitrosamine-induced" exact="hepatocellular carcinoma" post="experimental model, it was shown that carvacrol supplementation significantly"/>
   <result pre="peroxidase, and glutathione reductase), thereby showing potent anticancer effect in" exact="liver cancer" post="( 34 ). Similarly, in another study, carvacrol administration"/>
   <result pre="and glutathione reductase), thereby showing potent anticancer effect in liver" exact="cancer" post="( 34 ). Similarly, in another study, carvacrol administration"/>
   <result pre="the SRB assay against the HepG2 human experimental model of" exact="hepatocellular carcinoma." post="As indicated in Fig. 2a, the essential oil demonstrated"/>
   <result pre="Similar results were obtained when other experimental models of different" exact="cancer" post="types were used (e.g. breast, colon, and lung adenocarcinomas)"/>
   <result pre="the observed cytotoxicity of O. dictamnus essential is specific toward" exact="cancer" post="cells, our initial results supported this notion. Nevertheless, this"/>
   <result pre="inhibits cell proliferation and promotes apoptosis, two key properties for" exact="cancer" post="therapeutics ( 36 – 39 ). In our study,"/>
   <result pre="Molecular targets of dietary agents for prevention and therapy of" exact="cancer" post="Biochem Pharmacol 2006 71 1397 421 [16563357] 10 Gautam"/>
   <result pre="Manzoor N Rizvi MMA Cytotoxic effect of carvacrol on human" exact="cervical cancer" post="cells Biol Med 2011 3 307 12 28 Battey"/>
   <result pre="N Rizvi MMA Cytotoxic effect of carvacrol on human cervical" exact="cancer" post="cells Biol Med 2011 3 307 12 28 Battey"/>
   <result pre="K Kamaraj S Potential preventive effect of carvacrol against diethylnitrosamine-induced" exact="hepatocellular carcinoma" post="in rats Mol Cell Biochem 2012 360 51 60"/>
   <result pre="Arunasree KM Anti-proliferative effects of carvacrol on a human metastatic" exact="breast cancer" post="cell line, MDA-MB 231 Phytomedicine 2010 17 581 8"/>
   <result pre="KM Anti-proliferative effects of carvacrol on a human metastatic breast" exact="cancer" post="cell line, MDA-MB 231 Phytomedicine 2010 17 581 8"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4427012/results/search/disease/results.xml">
   <result pre="disorders, especially as eyewash to treat eye ailments such as" exact="conjunctivitis" post="and blepharitis that can be associated with bacterial infections."/>
   <result pre="as eyewash to treat eye ailments such as conjunctivitis and" exact="blepharitis" post="that can be associated with bacterial infections. Some Euphrasia"/>
   <result pre="the efficacy of Euphrasia eye drops in the treatment of" exact="conjunctivitis" post="[ 5 ] and a single clinical study investigating"/>
   <result pre="W. Prospective cohort trial of Euphrasia single-dose eye drops in" exact="conjunctivitis" post="Journal of Alternative and Complementary Medicine 2000 6 6"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4464069/results/search/disease/results.xml">
   <result pre="the mini-SEA (Social cognition and Emotional Assessment) in behavioral variant" exact="frontotemporal dementia" post=". Brain Imaging Behav. 8, 1– 6. [10.1007/s11682-013-9261-0] [24078043]"/>
   <result pre="mini-SEA (Social cognition and Emotional Assessment) in behavioral variant frontotemporal" exact="dementia" post=". Brain Imaging Behav. 8, 1– 6. [10.1007/s11682-013-9261-0] [24078043]"/>
   <result pre="( 2002). Theory of mind in patients with frontal variant" exact="frontotemporal dementia" post="and Alzheimer’s disease: theoretical and practical implications . Brain"/>
   <result pre="2002). Theory of mind in patients with frontal variant frontotemporal" exact="dementia" post="and Alzheimer’s disease: theoretical and practical implications . Brain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4468856/results/search/disease/results.xml">
   <result pre="Microbially produced peptides having potential application to the prevention of" exact="dental caries." post="Int. J. Antimicrob. Agents 9 95– 105. [10.1016/S0924-8579(97)00040-X] [18611824]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4489822/results/search/disease/results.xml">
   <result pre="&amp;lt;i&amp;gt;S&amp;lt;/i&amp;gt;. &amp;lt;i&amp;gt;sclerotiorum&amp;lt;/i&amp;gt; on greenhouse-grown oilseed rape plants. Material Concentration Disease" exact="suppression" post="efficacy (%) Dill seed essential oil 1.25 μL/mL 40.78"/>
   <result pre="Joo-Won S ( 2013) Effects of actinobacteria on plant disease" exact="suppression" post="and growth promotion. Appl Microbiol Biotechnol 97: 9621– 9636."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4503548/results/search/disease/results.xml">
   <result pre="radicals as well as for preventing the growth of THP-1" exact="leukemia" post="cells was better in essential oils with the highest"/>
   <result pre="determine the antiproliferative activity of these EOs on the THP-1" exact="leukemia" post="cell line. Also, the in vitro antioxidant activity was"/>
   <result pre="and Thymus species from Portugal were studied with the THP-1" exact="leukemia" post="cell line by treating these cells with increasing amounts"/>
   <result pre="between 62.5 and 125  μg/mL, also presented toxicity against 5RP7" exact="cancer" post="cells (c-H-ras transformed rat embryonic fibroblasts) [ 20 ]."/>
   <result pre="of the human colon adenocarcinoma (SW480), human breast adenocarcinoma (MCF7)," exact="choriocarcinoma" post="(JET 3), and monkey kidney (Vero) cell lines ["/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4517501/results/search/disease/results.xml">
   <result pre="were tested for cytotoxicity against a panel of six human" exact="cancer" post="cell lines. 74 Hydrodynamic Vortex CCS Ito et al."/>
   <result pre="eriocalyxin B ( K ≈ 1.6), which induced apoptosis in" exact="cancer" post="cells. Low-volume CCS was used to its full advantage"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4519343/results/search/disease/results.xml">
   <result pre="ORs are known to be over-expressed in certain types of" exact="cancer" post="and diabetes and it will be interesting to decode"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4525464/results/search/disease/results.xml">
   <result pre="of experience. According to Dioscorides, thyme was used to treat" exact="asthma" post="and loosen congestion in the throat and stomach ["/>
   <result pre="and 17th centuries), wild thyme was used internally to treat" exact="malaria" post="and epilepsy [ 9 ]. The aerial part of"/>
   <result pre="centuries), wild thyme was used internally to treat malaria and" exact="epilepsy" post="[ 9 ]. The aerial part of T. serpyllum"/>
   <result pre="the hexane extract of this species is cytotoxic to 6" exact="cancer" post="cell lines (MDA-MB-231, MCF-7, HepG2, HCT-116, PC3, and A549)."/>
   <result pre="the hexane extract, aimed at improving its cytotoxic effects on" exact="cancer" post="cell lines, particularly liver cancer, on the basis of"/>
   <result pre="at improving its cytotoxic effects on cancer cell lines, particularly" exact="liver cancer," post="on the basis of which appropriate medicines can be"/>
   <result pre="thymol on peripheral blood mononuclear cell PBMC and acute promyelotic" exact="cancer" post="cell line HL-60 Chemico-Biological Interactions 2011 193 1 97"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4548039/results/search/disease/results.xml">
   <result pre="wide variety of infections including urinary tract infections, bacteremia, endocarditis," exact="meningitis" post="and soft tissue infections. Of 47 species known to"/>
   <result pre="important antimicrobial compound is tannin, in S. aromaticum, which also" exact="aids" post="the process of antimicrobial action [ 17 ]. The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4558530/results/search/disease/results.xml">
   <result pre="reproductive system disorders, skeletal distortion, cancer, weakening of bones, and" exact="myelofibrosis" post="( Zinedine et al., 2007 ). In our recent"/>
   <result pre="Ayurveda. The plant has been traditionally used in management of" exact="common cold," post="asthmatic illnesses, skin problems, urogenital infections, digestive, neurological and"/>
   <result pre="and also showed ameliorative effects on in sciatic nerve transection-induced" exact="neuropathy" post="in rats ( Muthuraman et al., 2008 ). In"/>
   <result pre="2008). Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced" exact="neuropathy" post="in rats. J. Ethnopharmacol. 120 56– 62. [10.1016/j.jep.2008.07.049] [18762236]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4566093/results/search/disease/results.xml">
   <result pre="zone olfactory sensory neuron-defective mutant mice by targeted expression of" exact="diphtheria" post="toxin A gene. Mutant mice lacking all olfactory sensory"/>
   <result pre="mice) and (2) a knock-in mouse in which the Cre-inducible" exact="diphtheria" post="toxin A gene was introduced into the neuron-specific enolase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4567485/results/search/disease/results.xml">
   <result pre="example neuron, Extended Data Fig. 4e; population, Fig. 2c). This" exact="suppression" post="could not be fully explained by a shift in"/>
   <result pre="baseline activity ( Extended Data Fig. 7a–d). Moreover, the dopamine" exact="suppression" post="was not due to an association between blue light"/>
   <result pre="excitation to reward expectation (Type 2), and one with sustained" exact="suppression" post="to reward expectation (Type 3). Type 1 neurons were"/>
   <result pre="this cluster; the other three light-identified dopamine neurons showed phasic" exact="suppression" post="to reward and were clustered as Type 3. Since"/>
   <result pre="experiments. In the odour-based experiment ( Fig. 1), the average" exact="suppression" post="of dopamine reward responses was 52.7 percent, compared to"/>
   <result pre="[16865686] 32 Vong L Leptin action on GABAergic neurons prevents" exact="obesity" post="and reduces inhibitory tone to POMC neurons Neuron 2011"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4579641/results/search/disease/results.xml">
   <result pre="constituent of different essential oils with antimycobacterial activity against Mycobacterium" exact="tuberculosis" post="and Mycobacterium bovis 10.1186/s12906-015-0858-2 contrib: CONT Sergio Andrade-Ochoa Guadalupe"/>
   <result pre="Methods Twenty-five constituents of essential oils were evaluated against Mycobacterium" exact="tuberculosis" post="H37Rv and Mycobacterium bovis AN5 by the Alamar Blue"/>
   <result pre="synthetized as potential new antimycobacterial agents. Background Tuberculosis is an" exact="infectious disease" post="caused by Mycobacterium tuberculosis and other mycobacteria including Mycobacterium"/>
   <result pre="agents. Background Tuberculosis is an infectious disease caused by Mycobacterium" exact="tuberculosis" post="and other mycobacteria including Mycobacterium bovis. It is estimated"/>
   <result pre="that one-third of the world population is infected with M." exact="tuberculosis" post="and 5–10 % of them will develop clinical symptoms"/>
   <result pre="[ 1 ]. The increase in the incidence of clinical" exact="tuberculosis" post="is associated with increasing reports of new cases of"/>
   <result pre="of new drugs is critical for the future control of" exact="tuberculosis" post="(TB) and a number of promising compounds are currently"/>
   <result pre="phenylporpanes that are constituent of different essential oils, against M." exact="tuberculosis" post="(H37Rv) and M. bovis (AN5) using the Alamar Blue"/>
   <result pre="strains used in this study were H37Rv strain of M." exact="tuberculosis" post="and AN5 strain of M. bovis, both obtained from"/>
   <result pre="(G-Biosciences, 786–519), and 0.2 % Glycerol at 37 °C. M." exact="tuberculosis" post="was grown on Difco Middlebrook 7H11 agar (BD Biosciences,"/>
   <result pre="essential oils was evaluated on the H37Rv strain of M." exact="tuberculosis" post="and AN5 M. bovis strain by the Alamar Blue"/>
   <result pre="1 Chemical structures of terpenes and phenylpropanes evaluated against Mycobacterium" exact="tuberculosis" post="and Mycobacterium bovis and studied by molecular modeling technique."/>
   <result pre="Discussion In vitro potency of terpenes and phenylpropanes against M." exact="tuberculosis" post="and M. bovis The major components of the essential"/>
   <result pre="compounds tested, a higher antimycobacterial activity was observed for M." exact="tuberculosis" post="strain as compared to M. bovis (average MIC for"/>
   <result pre="strain as compared to M. bovis (average MIC for M." exact="tuberculosis" post="H37Rv was 22.78 μg/mL and average MIC for M."/>
   <result pre="values of 0.78 and 2.02 μg/mL against strain of M." exact="tuberculosis" post="and M. bovis respectively. On the other hand, carvacrol"/>
   <result pre="3.12 μg/mL for cinnamaldehyde; in both cases with the M." exact="tuberculosis" post="strain. In the case of M. bovis, cinnamic acid"/>
   <result pre="Table 1 Antimycobacterial activity of terpenes and phenylpropanes against M." exact="tuberculosis" post="and M. bovis Compounds Antimycobacterial activity (μg/mL) M. tuberculosis"/>
   <result pre="M. tuberculosis and M. bovis Compounds Antimycobacterial activity (μg/mL) M." exact="tuberculosis" post="M. bovis MIC MIC 1 Cinnamic Acid 8.16 ± 3.32 FG"/>
   <result pre="MIC results were 6.25, 12.5 and 25 μg/mL for M." exact="tuberculosis" post="respectively. Geranylgeraniol and geranylgeranyl acetate have been identified as"/>
   <result pre="have been identified as potent and selective inhibitors against M." exact="tuberculosis" post="with a MIC of 1.56 and 3.13 μg/mL respectively"/>
   <result pre="Antimycobacterial activity assays using the Alamar Blue technique against M." exact="tuberculosis" post="and M. bovis showed that thymol and carvacrol (major"/>
   <result pre="been used as a synergist with drugs traditionally used in" exact="tuberculosis" post="treatment [ 34 ]. The deleterious effect on structure"/>
   <result pre="activity The QSAR model for the H37Rv strain of M." exact="tuberculosis" post="that showed a statistical significance for structural properties included"/>
   <result pre="for molecules using a training set for models of M." exact="tuberculosis" post="is shown in Fig. 2. The statistics for other"/>
   <result pre=". Fig. 2 Predicted versus experimental antimycobacterial activity against M." exact="tuberculosis" post="for molecules in the training set used. a Structural"/>
   <result pre="summary of the statistics QSAR models for activity against M." exact="tuberculosis" post="Parameter Structure-activity relationship Parameter Property-Activity Relationship Model 2 Model"/>
   <result pre="(MlogP) shows the higher contribution to the activity against M." exact="tuberculosis" post="in the QSAR model. For M. bovis QSAR model,"/>
   <result pre="of plant-derived natural products as potential inhibitors of the Mycobacterium" exact="tuberculosis" post="proteasome BMC Complement. Altern. Med. 2014 14 1 400"/>
   <result pre="( Laurus nobilis) and anise ( Pimpinella anisum) against Mycobacterium" exact="tuberculosis" post="Adv in Biol Chem 2013 3 480 484 [10.4236/abc.2013.35052]"/>
   <result pre="BACTEC 460 system for high-throughput screening of compounds against Mycobacterium" exact="tuberculosis" post="and Mycobacterium avium Antimicrob Agents Chemother 1997 41 5"/>
   <result pre="Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium" exact="tuberculosis" post="chorismate mutase inhibitors J Enzyme Inhib Med Chem 2013"/>
   <result pre="antimycobacterium activity of the constituents from Ocimum basilicum against Mycobacterium" exact="tuberculosis" post="J Ethnopharmacol 2012 144 1 220 222 [10.1016/j.jep.2012.08.003] [22982011]"/>
   <result pre="of antituberculous drugs with cerulenin and trans‐cinnamic acid against Mycobacterium" exact="tuberculosis" post="FEMS Immunol Med Microbiol 1998 21 2 149 157"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4588114/results/search/disease/results.xml">
   <result pre="findings support that olfaction is altered in AN and in" exact="obesity" post="and indicates toward there being little to no difference"/>
   <result pre="dysfunction in a number of major psychiatric disorders, including schizophrenia," exact="obsessive-compulsive disorder," post="depression, and dementia (Atanasova et al., 2008 ; Rotge"/>
   <result pre="of major psychiatric disorders, including schizophrenia, obsessive-compulsive disorder, depression, and" exact="dementia" post="(Atanasova et al., 2008 ; Rotge et al., 2009"/>
   <result pre="were combined with the following components related to EDs [body-mass," exact="eating disorder," post="abnormal eating, anorexia nervosa, bulimia nervosa, obesity, binge-eating disorder,"/>
   <result pre="following components related to EDs [body-mass, eating disorder, abnormal eating," exact="anorexia nervosa," post="bulimia nervosa, obesity, binge-eating disorder, eating disorder not otherwise"/>
   <result pre="related to EDs [body-mass, eating disorder, abnormal eating, anorexia nervosa," exact="bulimia nervosa," post="obesity, binge-eating disorder, eating disorder not otherwise specified (EDNOS)]."/>
   <result pre="disorder, abnormal eating, anorexia nervosa, bulimia nervosa, obesity, binge-eating disorder," exact="eating disorder" post="not otherwise specified (EDNOS)]. Databases were searched from 1966"/>
   <result pre="9.0 HC = 45.5, sd = 9.1 N/A n/a The" exact="eating disorder" post="group scored significantly lower for threshold and significantly higher"/>
   <result pre="greater prevalence of hyposmia + M, males; F, females; AN," exact="anorexia nervosa;" post="BN, bulimia nervosa; ED, eating disorders; HC, human control;"/>
   <result pre="hyposmia + M, males; F, females; AN, anorexia nervosa; BN," exact="bulimia nervosa;" post="ED, eating disorders; HC, human control; RT, restricting type;"/>
   <result pre="quantitative self-rating scale for depression; EAT, Eating Attitude Test; EDNOS," exact="eating disorder" post="not otherwise specified; DIA-X/M-CIDI, Munich-Composite International Diagnostic Interview; EDFHI,"/>
   <result pre="disorder and 6 (43%) studied more than one disorder (mainly" exact="anorexia nervosa," post="bulimia nervosa and/or obesity). Eleven (78.6%) of the studies"/>
   <result pre="6 (43%) studied more than one disorder (mainly anorexia nervosa," exact="bulimia nervosa" post="and/or obesity). Eleven (78.6%) of the studies included participants"/>
   <result pre="al., 2012 ) and one (7.1%) looked at AN and" exact="obesity" post="(Fernández-Aranda et al., 2015 ). The AN studies amount"/>
   <result pre="Fernández-Aranda et al. ( 2015 ). Compared to other EDs," exact="anorexia nervosa" post="shares the most number of studies with olfactory capacity."/>
   <result pre="Fernández-Aranda et al., 2015 ) that examined smell capacity in" exact="obesity" post="in humans were found and another study (Simchen et"/>
   <result pre="(13.8). The findings are somewhat similar to that of the" exact="obesity" post="studies considered in this review except that what is"/>
   <result pre="dysfunction as a possible contributing factor to the progress of" exact="obesity" post="(Richardson et al., 2004 ). The number of olfactory"/>
   <result pre="). The number of olfactory studies conducted on individuals with" exact="obesity" post="is very limited. It can roughly be deduced from"/>
   <result pre="capacity (Cameron et al., 2012 ), whereas hyperlipidemic diet and" exact="hyperinsulinemia" post="may cause impairment in the olfactory capacity (Lacroix et"/>
   <result pre="Rolls B. J. ( 1995). Olfactory dysfunction in anorexia and" exact="bulimia nervosa." post="Int. J. Eat. Disord. 18, 71– 77. [7670445] Fernández-Aranda"/>
   <result pre="T. Tregellas J. R. . ( 2012). Anorexia nervosa and" exact="obesity" post="are associated with opposite brain reward response. Neuropsychopharmacology 37,"/>
   <result pre="Sandler L. Leshem M. ( 2012). Intact sensory function in" exact="anorexia nervosa." post="Am. J. Clin. Nutrit. 95, 272– 282. [10.3945/ajcn.111.020131] [22205316]"/>
   <result pre="Lack of association of body composition and functionality variables with" exact="metabolic syndrome" post="in the elderly . Metabol. Synd. Relat. Disord. 12,"/>
   <result pre="M. Birmingham C. L. ( 1995). Olfactory identification ability in" exact="anorexia nervosa." post="J. Psychiatry Neurosci. 20, 283– 286. [7647081] Lacroix M."/>
   <result pre="S. C. . ( 2010). Olfactory deficits in patients with" exact="anorexia nervosa." post="Eur. Eat. Disord. Rev. 18, 385– 389. [10.1002/erv.1010] [20821739]"/>
   <result pre="M. . ( 2009). Meta-analysis of brain volume changes in" exact="obsessive-compulsive disorder." post="Biol. Psychiatry 65, 75– 83. [10.1016/j.biopsych.2008.06.019] [18718575] Schecklmann M."/>
   <result pre="M. Romanos M. ( 2012). Olfaction in child and adolescent" exact="anorexia nervosa." post="Eur. Soc. Clin. Neuropharmacol. 119, 721– 728. [10.1007/s00702-011-0752-0] [22183089]"/>
   <result pre="Anzinger A. . ( 2008). Olfactory performance of patients with" exact="anorexia nervosa" post="and healthy subjects in hunger and satiety . Rhinology"/>
   <result pre="Bueno B. . ( 2011). Olfactory identification and discrimination in" exact="obsessive-compulsive disorder," post="Depress. Anxiety 28, 932– 940. [10.1002/da.20836] [21618671] Simchen U."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4628703/results/search/disease/results.xml">
   <result pre="1. Introduction Hepatocellular carcinoma (HCC) is the sixth most common" exact="cancer" post="worldwide, accounting for 9.1% of all cancers and an"/>
   <result pre="year. It is considered to be the third cause of" exact="cancer" post="related deaths (692,000 cases). The highest incidence rates of"/>
   <result pre="Asia and sub-Saharan Africa [ 1 ]. The prognosis for" exact="liver cancer" post="is very poor (overall ratio of mortality to incidence"/>
   <result pre="and sub-Saharan Africa [ 1 ]. The prognosis for liver" exact="cancer" post="is very poor (overall ratio of mortality to incidence"/>
   <result pre="which represents the leading cause of death from all other" exact="cancer" post="sites [ 3 ]. HCC has nearly doubled over"/>
   <result pre="nearly doubled over the last decade among patients with chronic" exact="liver disease" post="(CLD) [ 4 ]. HBV and HCV infections are"/>
   <result pre="the most important risk factors associated with progression from chronic" exact="hepatitis" post="to cirrhosis and, eventually, to HCC. In spite of"/>
   <result pre="important risk factors associated with progression from chronic hepatitis to" exact="cirrhosis" post="and, eventually, to HCC. In spite of the advances"/>
   <result pre="chemopreventive agents that act on the early molecular events of" exact="cancer" post="initiation by preventing, delaying, or reversing epithelial-mesenchymal transition, as"/>
   <result pre="as well as those that act as therapeutic agents for" exact="cancer" post="progression [ 5 , 6 ]. Using chemopreventive agents"/>
   <result pre="decrease of carcinogenic agents effects is very promising target for" exact="cancer" post="therapy [ 7 ]. Recently, increasing attention has been"/>
   <result pre=", 9 ]. Most of these bioactive substances exert their" exact="cancer" post="chemotherapeutic activity by modulating signal transduction pathways that are"/>
   <result pre="treatment response in employing a plant derived-bioactive substance to decrease" exact="breast cancer" post="mortality. In many developed countries herbal medicines are achieving"/>
   <result pre="response in employing a plant derived-bioactive substance to decrease breast" exact="cancer" post="mortality. In many developed countries herbal medicines are achieving"/>
   <result pre="], and antifertility activity [ 19 ], obesity, diabetes, and" exact="cancer" post="treatment [ 20 , 21 ]. Flavonoids have high"/>
   <result pre="which is called diosgenin that induces apoptosis in HT-29 human" exact="colon cancer" post="cells [ 23 ]; besides it plays a role"/>
   <result pre="is called diosgenin that induces apoptosis in HT-29 human colon" exact="cancer" post="cells [ 23 ]; besides it plays a role"/>
   <result pre="some constituent of alkaloids, &quot;trigonelline,&quot; has a potential role in" exact="cancer" post="treatment [ 25 ]. Another active agent identified in"/>
   <result pre="HL-60 [ 26 ]. The prototypic molecular change associated with" exact="cancer" post="is mutation of tumor suppressor p53, which is inactivated"/>
   <result pre="arrest or cell death. Understanding the molecular mechanism associated with" exact="hepatocellular carcinoma" post="improves screening and treatment of the disease [ 39"/>
   <result pre="scientists worldwide, there is constant increase in the incidence of" exact="hepatocellular carcinoma" post="during the last two decades [ 44 ]. Successful"/>
   <result pre="[ 45 , 46 ] and antioxidant properties against experimental" exact="cataract" post="[ 47 ]. In the present study, HepG2 cell"/>
   <result pre="of the FCE active ingredients, induced apoptosis in HT-29 human" exact="colon cancer" post="cells [ 23 ]. Furthermore, it was reported that"/>
   <result pre="the FCE active ingredients, induced apoptosis in HT-29 human colon" exact="cancer" post="cells [ 23 ]. Furthermore, it was reported that"/>
   <result pre="factor (AIF) and modulation of caspase-3 activity in different human" exact="cancer" post="cells [ 52 ]. In prostate cancer cells, PC-3,"/>
   <result pre="activity in different human cancer cells [ 52 ]. In" exact="prostate cancer" post="cells, PC-3, a cell line expressing wild type p53,"/>
   <result pre="in different human cancer cells [ 52 ]. In prostate" exact="cancer" post="cells, PC-3, a cell line expressing wild type p53,"/>
   <result pre="alteration in PCNA structure might contribute to DNA-damage accumulation in" exact="cancer" post="cells. The present study was aimed at evaluating the"/>
   <result pre="for the treatment of cancer. Quercetin modulates the pathway toward" exact="suppression" post="of lymphoma by downregulating PI3K-AKT1 and upregulating p53 pathways"/>
   <result pre="treatment of cancer. Quercetin modulates the pathway toward suppression of" exact="lymphoma" post="by downregulating PI3K-AKT1 and upregulating p53 pathways as well"/>
   <result pre="Fraumeni J. F. Jr. International trends and patterns of primary" exact="liver cancer" post="International Journal of Cancer 2001 94 2 290 296"/>
   <result pre="J. F. Jr. International trends and patterns of primary liver" exact="cancer" post="International Journal of Cancer 2001 94 2 290 296"/>
   <result pre="Khalifa M. O. Dorry A. K. E. Epidemiological characteristics of" exact="hepatocellular carcinoma" post="in Egypt: a retrospective analysis of 1313 cases Liver"/>
   <result pre="Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human" exact="breast cancer" post="cells Oncogene 2005 24 5 746 760 [10.1038/sj.onc.1208203] [2-s2.0-13444263403]"/>
   <result pre="promotes homotypic adhesion and inhibits invasive characteristics of human breast" exact="cancer" post="cells Oncogene 2005 24 5 746 760 [10.1038/sj.onc.1208203] [2-s2.0-13444263403]"/>
   <result pre="transducer and activator of transcription 5a promotes differentiation of mammary" exact="cancer" post="cells through reversal of epithelial-mesenchymal transition Cancer Science 2008"/>
   <result pre="extracts induce cell cycle arrest and apoptosis in human MCF-7" exact="breast cancer" post="cells Cancer Letters 2006 241 1 124 134 [10.1016/j.canlet.2005.10.027]"/>
   <result pre="induce cell cycle arrest and apoptosis in human MCF-7 breast" exact="cancer" post="cells Cancer Letters 2006 241 1 124 134 [10.1016/j.canlet.2005.10.027]"/>
   <result pre="( Viscum album) extracts, and/or diallyl trisulfide (DATS) to inhibit" exact="breast cancer" post="stem cell characteristics, epithelial-mesenchymal transition, and invasion potential Molecular"/>
   <result pre="Viscum album) extracts, and/or diallyl trisulfide (DATS) to inhibit breast" exact="cancer" post="stem cell characteristics, epithelial-mesenchymal transition, and invasion potential Molecular"/>
   <result pre="N. Fenugreek, a naturally occurring edible spice, kills MCF-7 human" exact="breast cancer" post="cells via an apoptotic pathway Asian Pacific Journal of"/>
   <result pre="Fenugreek, a naturally occurring edible spice, kills MCF-7 human breast" exact="cancer" post="cells via an apoptotic pathway Asian Pacific Journal of"/>
   <result pre="S. A. Chemopreventive activities of Trigonella foenum graecum (Fenugreek) against" exact="breast cancer" post="Cell Biology International 2005 29 8 687 694 [10.1016/j.cellbi.2005.04.004]"/>
   <result pre="A. Chemopreventive activities of Trigonella foenum graecum (Fenugreek) against breast" exact="cancer" post="Cell Biology International 2005 29 8 687 694 [10.1016/j.cellbi.2005.04.004]"/>
   <result pre="formation in F344 rats and induces apoptosis in HT-29 human" exact="colon cancer" post="cells Cancer Epidemiology Biomarkers and Prevention 2004 13 8"/>
   <result pre="in F344 rats and induces apoptosis in HT-29 human colon" exact="cancer" post="cells Cancer Epidemiology Biomarkers and Prevention 2004 13 8"/>
   <result pre="apoptosis in leukemic cell line H-60, but not in gastric" exact="cancer" post="cell line KATO III International Journal of Molecular Medicine"/>
   <result pre="26 [2-s2.0-1842833886] [12469212] 27 Yu Q. Restoring p53-mediated apoptosis in" exact="cancer" post="cells: new opportunities for cancer therapy Drug Resistance Updates"/>
   <result pre="Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for" exact="cancer" post="therapy Drug Resistance Updates 2006 9 1-2 19 25"/>
   <result pre="T. Schirmacher P. Dysregulation of growth factor signaling in human" exact="hepatocellular carcinoma" post="Oncogene 2006 25 27 3787 3800 [10.1038/sj.onc.1209556] [2-s2.0-33745552897] [16799620]"/>
   <result pre="E. p53, Ki-67, and serum alpha feto-protein as predictors of" exact="hepatocellular carcinoma" post="recurrence in liver transplant patients Modern Pathology 2005 18"/>
   <result pre="33 Stoimenov I. Helleday T. PCNA on the crossroad of" exact="cancer" post="Biochemical Society Transactions 2009 37 part 3 605 613"/>
   <result pre="Deng H. Li H. Feng D.-Y. Expression of cyclins in" exact="hepatocellular carcinoma" post="and its correlation to tumor cell apoptosis Chinese Journal"/>
   <result pre="51 McGill G. Fisher D. E. Apoptosis in tumorigenesis and" exact="cancer" post="therapy Frontiers in Bioscience 1997 2 353 379 [2-s2.0-0000565243]"/>
   <result pre="factor (AIF) and modulation of caspase-3 activity in different human" exact="cancer" post="cells Cell Research 2004 14 3 188 196 [10.1038/sj.cr.7290219]"/>
   <result pre="p53 and p21 determine the sensitivity of noscapine-induced apoptosis in" exact="colon cancer" post="cells Cancer Research 2007 67 8 3862 3870 [10.1158/0008-5472.can-06-4282]"/>
   <result pre="and p21 determine the sensitivity of noscapine-induced apoptosis in colon" exact="cancer" post="cells Cancer Research 2007 67 8 3862 3870 [10.1158/0008-5472.can-06-4282]"/>
   <result pre="Syed N. A. Khoja K. K. Fenugreek induced apoptosis in" exact="breast cancer" post="MCF-7 cells mediated independently by fas receptor change Asian"/>
   <result pre="N. A. Khoja K. K. Fenugreek induced apoptosis in breast" exact="cancer" post="MCF-7 cells mediated independently by fas receptor change Asian"/>
   <result pre="proliferating cell nuclear antigen index predict poor patient outcome of" exact="hepatocellular carcinoma" post="after resection Oncology Reports 2007 18 6 1417 1426"/>
   <result pre="Wilkens L. R. Kolonel L. N. Intake of flavonoids and" exact="lung cancer" post="Journal of the National Cancer Institute 2000 92 2"/>
   <result pre="L. R. Kolonel L. N. Intake of flavonoids and lung" exact="cancer" post="Journal of the National Cancer Institute 2000 92 2"/>
   <result pre="T. Inhibitory effects of naringenin on tumor growth in human" exact="cancer" post="cell lines and sarcoma S-180-implanted mice Biological and Pharmaceutical"/>
   <result pre="naringenin on tumor growth in human cancer cell lines and" exact="sarcoma" post="S-180-implanted mice Biological and Pharmaceutical Bulletin 2005 28 3"/>
   <result pre="[15744083] 68 Maurya A. K. Vinayak M. Quercetin regresses Dalton's" exact="lymphoma" post="growth via suppression of PI3K/AKT signaling leading to upregulation"/>
   <result pre="A. K. Vinayak M. Quercetin regresses Dalton's lymphoma growth via" exact="suppression" post="of PI3K/AKT signaling leading to upregulation of p53 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4641935/results/search/disease/results.xml">
   <result pre="effects on several inflammatory disorders including encephalomyelitis, colitis, Edema, and" exact="arthritis" post="through suppression of prostaglandins and leukotrienes as inflammatory mediators"/>
   <result pre="several inflammatory disorders including encephalomyelitis, colitis, Edema, and arthritis through" exact="suppression" post="of prostaglandins and leukotrienes as inflammatory mediators [ 1"/>
   <result pre="symptoms in patients with allergic diseases such as bronchial asthma," exact="allergic rhinitis" post="[ 5 ]. Central analgesic effects of methanol and"/>
   <result pre="in patients with allergic diseases such as bronchial asthma, allergic" exact="rhinitis" post="[ 5 ]. Central analgesic effects of methanol and"/>
   <result pre="12 weeks after toluene exposure showed no histopathological changes of" exact="neurodegeneration" post="in the frontal cortex and brain stem. In the"/>
   <result pre="]. Similarly the effects of N. sativa and TQ on" exact="neurodegeneration" post="in hippocampus after chronic toluene exposure in rats were"/>
   <result pre="hippocampus after chronic toluene exposure and no histopathological changes of" exact="neurodegeneration" post="in treatment group have been reported [ 13 ]."/>
   <result pre="The protective effect of Nigella sativa and its constituents on" exact="neurodegeneration" post="and Alzheimer disease (AD) was shown in Table 2"/>
   <result pre="reducing the frequency of seizures in childhood (13 years old)" exact="epilepsy" post="were evaluated. All the patients (20 children) received extract"/>
   <result pre="25 ]. The effect of Nigella sativa and TQ on" exact="epilepsy" post="was shown in Table 3 . 6. Anti-Parkinson Effects"/>
   <result pre="8. Clinical Applications In a clinical trial forty-two patients with" exact="rheumatoid arthritis" post="(RA) were assigned to intervention group receiving capsules of"/>
   <result pre="Clinical Applications In a clinical trial forty-two patients with rheumatoid" exact="arthritis" post="(RA) were assigned to intervention group receiving capsules of"/>
   <result pre="symptoms in patients with allergic diseases such as bronchial asthma," exact="allergic rhinitis," post="and atopic eczema and all extract of N. sativa"/>
   <result pre="13 Kanter M. Nigella sativa and derived thymoquinone prevents hippocampal" exact="neurodegeneration" post="after chronic toluene exposure in rats Neurochemical Research 2008"/>
   <result pre="curcumin and Nigella sativa oil in the pilocarpine model of" exact="epilepsy" post="in comparison with valproate Epilepsy – Behavior 2012 24"/>
   <result pre="The protective effect of Nigella sativa and its constituents on" exact="neurodegeneration" post="and Alzheimer disease (AD). Drug Dose Result References N."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4664613/results/search/disease/results.xml">
   <result pre="to ASD symptom, six were announced with ASD or with" exact="pervasive developmental disorder" post="and four as Asperger. The NT control participants had"/>
   <result pre="intensity, pleasantness and familiarity) in ASD adults (including both classical" exact="autism" post="and Asperger’s syndrome) and controls; whereas olfactory thresholds, odor"/>
   <result pre="children, Dudova and Hrdlicka (2013) found no significant correlation between" exact="autism" post="severity and odor detection, odor pleasantness ratings or odor"/>
   <result pre="Walker I. Baron-Cohen S. ( 2014). Enhanced olfactory sensitivity in" exact="autism" post="spectrum conditions. Mol. Autism 5 53 [10.1186/2040-2392-5-53] Beighley J."/>
   <result pre="( 2013). Food selectivity in children with and without an" exact="autism" post="spectrum disorder: investigation of diagnosis and age. Res. Dev."/>
   <result pre="( 2014). &quot;Sensory sensitivity and food selectivity in children with" exact="autism" post="spectrum disorder,&quot; in Comprehsensive Guide to Autism eds Patel"/>
   <result pre="Hrdlicka M. ( 2013). Olfactory functions are not associated with" exact="autism" post="severity in autism spectrum disorders. Neuropsychiatr. Dis. Treat. 9"/>
   <result pre="2013). Olfactory functions are not associated with autism severity in" exact="autism" post="spectrum disorders. Neuropsychiatr. Dis. Treat. 9 1847– 1851. [10.2147/NDT.S54893]"/>
   <result pre="V. Mottron L. Frasnelli J. ( 2013). Olfaction in the" exact="autism" post="spectrum. Perception 42 341– 355. [10.1068/p7337] [23837210] Galloway A."/>
   <result pre="Ververi A. Antoniadis A. Zafeiriou D. I. ( 2010). Childhood" exact="autism" post="and auditory system abnormalities. Pediatr. Neurol. 42 309– 314."/>
   <result pre="Gast D. L. ( 2006). Feeding problems in children with" exact="autism" post="spectrum disorders: a review. Focus Autism Other Dev. Disabl."/>
   <result pre="C. ( 2008). Feeding and eating behaviors in children with" exact="autism" post="and typically developing children. J. Autism Dev. Disord. 38"/>
   <result pre="of food selectivity and other feeding problems in children with" exact="autism" post="spectrum disorders. Res. Autism Spectr. Disord. 3 455– 461."/>
   <result pre="B. J. ( 2011). Differential olfactory identification in children with" exact="autism" post="and Asperger’s disorder: a comparative and longitudinal study. J."/>
   <result pre="D. Gisel E. ( 2013). &quot;Feeding issues associated with the" exact="autism" post="spectrum disorder,&quot; in Recent Advances in Autism Spectrum Disorders"/>
   <result pre="255. [10.1016/j.appet.2008.09.018] [18940212] O’Connor K. ( 2012). Auditory processing in" exact="autism" post="spectrum disorder: a review. Neurosci. Biobehav. Rev. 36 836–"/>
   <result pre="A. E. ( 2014). Impaired tactile processing in children with" exact="autism" post="spectrum disorder. J. Neurophysiol. 111 1803– 1811. [10.1152/jn.00890.2013] [24523518]"/>
   <result pre="( 2013). Feeding problems and nutrient intake in children with" exact="autism" post="spectrum disorders: a meta-analysis and comprehensive review of the"/>
   <result pre="E. McAleer P. Pollick F. E. ( 2009). Vision in" exact="autism" post="spectrum disorders. Vis. Res. 49 2705– 2739. [10.1016/j.visres.2009.08.005] [19682485]"/>
   <result pre="( 2012). Olfactory detection thresholds and adaptation in adults with" exact="autism" post="spectrum condition. J. Autism Dev. Disord. 42 905– 909."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4670656/results/search/disease/results.xml">
   <result pre="of activities on reducing anxiety, depression [ 2 ], and" exact="cancer" post="pain and on increasing sedative activities [ 3 ,"/>
   <result pre="able to reduce the low density lipoprotein (LDL) and prevent" exact="arteriosclerosis" post="[ 28 ]. Cold-pressed C. grandis oils also contained"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4707358/results/search/disease/results.xml">
   <result pre="TQ against H 2O 2-induced oxidative stress in differentiated human" exact="neuroblastoma" post="SH-SY5Y cells. Their neuroprotective properties were assessed by cell"/>
   <result pre="system (GeXP). 2. Materials and Methods 2.1. Reagents The human" exact="neuroblastoma" post="SH-SY5Y cell line was purchased from ATCC (VA, USA)."/>
   <result pre="antioxidant systems, cell death is likely and is implicated in" exact="neurodegeneration" post="[ 25 ]. In the presence of exogenous antioxidants"/>
   <result pre="Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced" exact="cancer" post="Chemico-Biological Interactions 2006 160 1 1 40 [10.1016/j.cbi.2005.12.009] [2-s2.0-32444433202]"/>
   <result pre="P. Redox-sensitive signaling factors as a novel molecular targets for" exact="cancer" post="therapy Drug Resistance Updates 2005 8 5 322 330"/>
   <result pre="T. Forloni G. JNK signalling: a possible target to prevent" exact="neurodegeneration" post="Current Pharmaceutical Design 2007 13 18 1875 1886 [10.2174/138161207780858384]"/>
   <result pre="U. Thymoquinone: fifty years of success in the battle against" exact="cancer" post="models Drug Discovery Today 2014 19 1 18 30"/>
   <result pre="brown rice attenuates hydrogen peroxide-induced oxidative stress in human SH-SY5Y" exact="neuroblastoma" post="cells: role of anti-apoptotic, pro-survival and antioxidant genes BMC"/>
   <result pre="effects of melittin on hydrogen peroxide-induced apoptotic cell death in" exact="neuroblastoma" post="SH-SY5Y cells BMC complementary and alternative medicine 2014 14,"/>
   <result pre="A. Duttaroy A. Feany M. B. Oxidative stress mediates tau-induced" exact="neurodegeneration" post="in Drosophila The Journal of Clinical Investigation 2007 117"/>
   <result pre="A. M. Kwon Y. K. Joung I. p62 protects SH-SY5Y" exact="neuroblastoma" post="cells against H 2O 2-induced injury through the PDK1/Akt"/>
   <result pre="J. A. Ackerman S. L. Oxidative stress, cell cycle, and" exact="neurodegeneration" post="Journal of Clinical Investigation 2003 111 6 785 793"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4724840/results/search/disease/results.xml">
   <result pre="2 ). At present, the first choice midication to treat" exact="toxoplasmosis" post="is combination of pyrimethamine and sulfadiazine. However, these medications"/>
   <result pre="efficacy of the &amp;lt;i&amp;gt;Bunium persicum&amp;lt;/i&amp;gt; (Boiss) essential oil against acute" exact="toxoplasmosis" post="in mice This study was carried out in strict"/>
   <result pre="University of Medical Science (Permit Number: 93/110). Establishment of acute" exact="toxoplasmosis" post="In this study, animal model of acute toxoplasmosis was"/>
   <result pre="of acute toxoplasmosis In this study, animal model of acute" exact="toxoplasmosis" post="was established as described elsewhere ( 13 ). Briefly,"/>
   <result pre="evaluate prophylactic effects of B. persicum essential oil on acute" exact="toxoplasmosis" post="in mice, two groups of mice were received B."/>
   <result pre="investigate therapeutic effects of B. persicum essential oil against acute" exact="toxoplasmosis" post="in mice, at first, 3 groups of mice were"/>
   <result pre="indicates prophylactic effects of B. persicum essential oil against acute" exact="toxoplasmosis" post="in mice model. Fig. 2: Prophylactic effects of &amp;lt;i&amp;gt;Bunium"/>
   <result pre="the time/mean time of death of infected mice with acute" exact="toxoplasmosis" post="The time/mean time of death of infected mice was"/>
   <result pre="the time/mean time of death of infected mice with acute" exact="toxoplasmosis" post="Results exhibited that the difference in the time/mean time"/>
   <result pre="and therapeutic effects of B. persicum essential oil against acute" exact="toxoplasmosis" post="in mice. Since last centuries, plants and their derivatives"/>
   <result pre="concentration of 0.1 ml/kg had potent prophylactic effects against acute" exact="toxoplasmosis" post="in mice and their survival was prolonged to 9"/>
   <result pre="prophylactic efficacy of the B. persicum essential oil against acute" exact="toxoplasmosis" post="in mice model. Results also provided the scientific evidence"/>
   <result pre="Coppini D Donzelli C Stellini R Manca N Fatal disseminated" exact="toxoplasmosis" post="during primary HIV infection. Curr HIV Res. 2007; 5:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4730278/results/search/disease/results.xml">
   <result pre="was selected in order to assess antitumor activity against experimental" exact="sarcoma" post="180 tumors. Toxicological effects related to the liver, spleen,"/>
   <result pre="health concern. More than 100 distinct types and subtypes of" exact="cancer" post="can be found within specific organs [ 1 ,"/>
   <result pre="tumor formation [ 4 ]. The major problems in treating" exact="cancer" post="are the loss of sensitivity of tumor cells to"/>
   <result pre="More than two thirds of the drugs currently used in" exact="cancer" post="treatments come directly from natural products, or have been"/>
   <result pre="also been reported to possess in vitro cytotoxic effects on" exact="cancer" post="cell lines [ 9 ]. The monoterpene perillyl alcohol"/>
   <result pre="was found to be cytotoxic to a wide variety of" exact="cancer" post="cells through advanced studies demonstrating its bioactivity as an"/>
   <result pre="that the perillaldehyde 8,9-epoxide exhibits high cytotoxic activity for 4" exact="cancer" post="cell lines (colon carcinoma, ovarian adenocarcinoma, glioblastoma, and leukemia),"/>
   <result pre="The effects of perillaldehyde 8,9-epoxide and perillyl alcohol on the" exact="sarcoma" post="180 tumor cells (S-180) into mice are presented in"/>
   <result pre="of perillaldehyde 8,9-epoxide and perillyl alcohol on animals inoculated with" exact="sarcoma" post="180 tumor cells (S-180). The graphs show tumor mass"/>
   <result pre="are important and provide insights as to their use for" exact="cancer" post="treatments [ 23 ]. Among monoterpenes, perillyl alcohol stands"/>
   <result pre="of antitumor drug activity is very important because most chemotherapeutic" exact="cancer" post="agents are non-specific in action; besides attacking tumors, they"/>
   <result pre="p &amp;lt; 0.05). These results suggest that perillaldehyde 8,9-epoxide caused" exact="leukopenia" post="at the doses tested and at the applied time"/>
   <result pre="[10.1002/ijc.29210] [25220842] 2. Hanahan D. Weinberg R.A. The hallmarks of" exact="cancer" post="Cell 2000 100 57 70 [10.1016/S0092-8674(00)81683-9] [10647931] 3. Carvalho"/>
   <result pre="S.R. Gutti R.K. Therapeutic potential of siRNA and DNAzymes in" exact="cancer" post="Tumour Biol. 2014 35 9505 9521 [10.1007/s13277-014-2477-9] [25149153] 6."/>
   <result pre="Bishayee A. Terpenoids as potential chemopreventive and therapeutic agents in" exact="liver cancer" post="World J. Hepatol. 2011 3 228 249 [10.4254/wjh.v3.i9.228] [21969877]"/>
   <result pre="A. Terpenoids as potential chemopreventive and therapeutic agents in liver" exact="cancer" post="World J. Hepatol. 2011 3 228 249 [10.4254/wjh.v3.i9.228] [21969877]"/>
   <result pre="M.G. Devaki T. Potential preventive effect of carvacrol against diethylnitrosamineinduced" exact="hepatocellular carcinoma" post="in rats Mol. Cell. Biochem. 2012 360 51 60"/>
   <result pre="thymol on peripheral blood mononuclear cell PBMC and acute promyelotic" exact="cancer" post="cell line HL-60 Chem. Biol. Interact. 2011 193 97"/>
   <result pre="Qureshi A. Tanner M.A. Gould M.N. Inhibition of DMBA-induced mammary" exact="cancer" post="by the monoterpene d-limonene Carcinogenesis 1984 5 661 664"/>
   <result pre="acid induced cell cycle arrest and apoptosis in non-small cell" exact="lung cancer" post="cells Cancer Lett. 2007 257 216 226 [10.1016/j.canlet.2007.07.020] [17888568]"/>
   <result pre="induced cell cycle arrest and apoptosis in non-small cell lung" exact="cancer" post="cells Cancer Lett. 2007 257 216 226 [10.1016/j.canlet.2007.07.020] [17888568]"/>
   <result pre="Wang Robert C. Elegbede A. Monoterpenes enhanced the sensitivity of" exact="head and neck cancer" post="cells to radiation treatment in vitro Anticancer Res. 2004"/>
   <result pre="Elegbede A. Monoterpenes enhanced the sensitivity of head and neck" exact="cancer" post="cells to radiation treatment in vitro Anticancer Res. 2004"/>
   <result pre="Burke Y.D. McKinzie J.H. Ayoubi S.A. Crowell P.L. Chemotherapy of" exact="pancreatic cancer" post="with the monoterpene perillyl alcohol Cancer Lett. 1995 96"/>
   <result pre="Y.D. McKinzie J.H. Ayoubi S.A. Crowell P.L. Chemotherapy of pancreatic" exact="cancer" post="with the monoterpene perillyl alcohol Cancer Lett. 1995 96"/>
   <result pre="Phase II trial of perillyl alcohol in patients with metastatic" exact="colorectal cancer" post="Int. J. Gastrointest. Cancer 2002 32 125 128 [10.1385/IJGC:32:2-3:125]"/>
   <result pre="II trial of perillyl alcohol in patients with metastatic colorectal" exact="cancer" post="Int. J. Gastrointest. Cancer 2002 32 125 128 [10.1385/IJGC:32:2-3:125]"/>
   <result pre="Stark M.J. Roach M.S.L. Sen S.E. Crowell P.L. Inhibition of" exact="pancreatic cancer" post="growth by the dietary isoprenoids farnesol and geraniol Lipids"/>
   <result pre="M.J. Roach M.S.L. Sen S.E. Crowell P.L. Inhibition of pancreatic" exact="cancer" post="growth by the dietary isoprenoids farnesol and geraniol Lipids"/>
   <result pre="Hentosh P. The isoprenoid perillyl alcohol inhibits telomerase activity in" exact="prostate cancer" post="cells Biochimie 2012 94 2639 2648 [10.1016/j.biochi.2012.07.028] [22902867] 28."/>
   <result pre="P. The isoprenoid perillyl alcohol inhibits telomerase activity in prostate" exact="cancer" post="cells Biochimie 2012 94 2639 2648 [10.1016/j.biochi.2012.07.028] [22902867] 28."/>
   <result pre="Lima M.A.S. Elmiro F.J.M. Costa-Lotufo L.V. In vivo growth-inhibition of" exact="sarcoma" post="180 by piplartine and peperine, two alkaloid amides from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4766438/results/search/disease/results.xml">
   <result pre="role in a fly’s daily life, like explosives, drugs and" exact="breast cancer" post="metabolites 29 45 . It may well be that"/>
   <result pre="in a fly’s daily life, like explosives, drugs and breast" exact="cancer" post="metabolites 29 45 . It may well be that"/>
   <result pre="M. et al. More than apples and oranges - detecting" exact="cancer" post="with a fruit fly’s antenna. Sci. Rep. 4, doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4786606/results/search/disease/results.xml">
   <result pre="in Brazil and the USA have been infested by the" exact="bacterial disease" post="Huanglongbing (HLB), which has led to a drop in"/>
   <result pre="component from Citrus and evidence for a potential role in" exact="breast cancer" post="prevention and treatment Oncol Rev 2010 5 31 42"/>
   <result pre="from Citrus and evidence for a potential role in breast" exact="cancer" post="prevention and treatment Oncol Rev 2010 5 31 42"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4799292/results/search/disease/results.xml">
   <result pre="roles in disease conditions such as inflammation and development of" exact="cancer" post="(Hyde and Missailidis 2009 ). Therefore, there is an"/>
   <result pre="dimeric flavonoid, isolated from M. glyptostroboides, exhibited antiviral activity against" exact="influenza" post="viruses A and B (Miki et al. 2008 )."/>
   <result pre="drug Tamiflu, possess its antiviral activity through inhibition of the" exact="influenza" post="viral sialidase (von Itzstein 2007 ). Anticancer activity Recently,"/>
   <result pre="M Yoshida I Hosokawa K Tsukui A Azuma M Anti" exact="influenza" post="virus activity of a red-fleshed potato anthocyanin Food Sci"/>
   <result pre="Furuhata K Yamada H Takahashi K Synthesis and evaluation of" exact="influenza" post="virus sialidase inhibitory activity of hinokiflavone-sialic acid conjugates Heterocycles"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="carvone/PMC4822282/results/search/disease/results.xml">
   <result pre="in plant foliar and floral metabolomes in response to the" exact="suppression" post="of the associated microbiota 10.1186/s12870-016-0767-7 contrib: CONT Albert Gargallo-Garriga"/>
   <result pre="of complexity similar to that of the plant organs. The" exact="suppression" post="of microbial communities by topical applications of antibiotics had"/>
   <result pre="of pyrogallol in the floral epiphytic community. Discussion Effects of" exact="suppression" post="of the epiphytic community on metabolic profiles The effect"/>
   <result pre="the global metabolomic expression of a plant due to the" exact="suppression" post="of its microbial community. The antibiotics were applied to"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
